'Ostéosarcome'
(id=14094436 ; fe=Ostéosarcome ; type=777 ; niveau=200 ;
luminosité=25 ;
somme entrante=382 creation date=2019-12-17 touchdate=2025-12-19 15:29:52.000) ≈ 1549 relations sortantes
- Ostéosarcome --
r_associated #0: 80 / 1 ->
chirurgie
n1=Ostéosarcome | n2=chirurgie | rel=r_associated | relid=0 | w=80
- Ostéosarcome --
r_associated #0: 29 / 0.363 ->
en:surgical operation
n1=Ostéosarcome | n2=en:surgical operation | rel=r_associated | relid=0 | w=29
- Ostéosarcome --
r_associated #0: 28 / 0.35 ->
tumeurs
n1=Ostéosarcome | n2=tumeurs | rel=r_associated | relid=0 | w=28
- Ostéosarcome --
r_associated #0: 27 / 0.338 ->
carcinologie
n1=Ostéosarcome | n2=carcinologie | rel=r_associated | relid=0 | w=27
- Ostéosarcome --
r_associated #0: 27 / 0.338 ->
carcinologie
(oncologie)
n1=Ostéosarcome | n2=carcinologie (oncologie) | rel=r_associated | relid=0 | w=27
- Ostéosarcome --
r_associated #0: 27 / 0.338 ->
maladies
n1=Ostéosarcome | n2=maladies | rel=r_associated | relid=0 | w=27
- Ostéosarcome --
r_associated #0: 27 / 0.338 ->
oncologie
n1=Ostéosarcome | n2=oncologie | rel=r_associated | relid=0 | w=27
- Ostéosarcome --
r_associated #0: 26 / 0.325 ->
en:specialized branches of medicine
n1=Ostéosarcome | n2=en:specialized branches of medicine | rel=r_associated | relid=0 | w=26
- Ostéosarcome --
r_associated #0: 26 / 0.325 ->
en:surgery
n1=Ostéosarcome | n2=en:surgery | rel=r_associated | relid=0 | w=26
- Ostéosarcome --
r_associated #0: 26 / 0.325 ->
pathologie
n1=Ostéosarcome | n2=pathologie | rel=r_associated | relid=0 | w=26
- Ostéosarcome --
r_associated #0: 25 / 0.313 ->
cancer
n1=Ostéosarcome | n2=cancer | rel=r_associated | relid=0 | w=25
- Ostéosarcome --
r_associated #0: 25 / 0.313 ->
en:surgical procedure
n1=Ostéosarcome | n2=en:surgical procedure | rel=r_associated | relid=0 | w=25
- Ostéosarcome --
r_associated #0: 25 / 0.313 ->
Spécialités médicales
n1=Ostéosarcome | n2=Spécialités médicales | rel=r_associated | relid=0 | w=25
- Ostéosarcome --
r_associated #0: 24 / 0.3 ->
médecine spécialisée
n1=Ostéosarcome | n2=médecine spécialisée | rel=r_associated | relid=0 | w=24
- Ostéosarcome --
r_associated #0: 24 / 0.3 ->
opération chirurgicale
n1=Ostéosarcome | n2=opération chirurgicale | rel=r_associated | relid=0 | w=24
- Ostéosarcome --
r_associated #0: 23 / 0.288 ->
spécialités médicales
n1=Ostéosarcome | n2=spécialités médicales | rel=r_associated | relid=0 | w=23
- Ostéosarcome --
r_associated #0: 22 / 0.275 ->
en:chirurgia
n1=Ostéosarcome | n2=en:chirurgia | rel=r_associated | relid=0 | w=22
- Ostéosarcome --
r_associated #0: 21 / 0.263 ->
cancérologie
n1=Ostéosarcome | n2=cancérologie | rel=r_associated | relid=0 | w=21
- Ostéosarcome --
r_associated #0: 21 / 0.263 ->
en:oncology
n1=Ostéosarcome | n2=en:oncology | rel=r_associated | relid=0 | w=21
- Ostéosarcome --
r_associated #0: 21 / 0.263 ->
médecine
n1=Ostéosarcome | n2=médecine | rel=r_associated | relid=0 | w=21
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
anaplasique
n1=Ostéosarcome | n2=anaplasique | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
aspect en rayon de soleil
n1=Ostéosarcome | n2=aspect en rayon de soleil | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
astrocytome
n1=Ostéosarcome | n2=astrocytome | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
astrocytome de grade IV
n1=Ostéosarcome | n2=astrocytome de grade IV | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
cancer des os
n1=Ostéosarcome | n2=cancer des os | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
cancer
(maladie)
n1=Ostéosarcome | n2=cancer (maladie) | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
cérébrale
n1=Ostéosarcome | n2=cérébrale | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
cerveau
n1=Ostéosarcome | n2=cerveau | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
condensante
n1=Ostéosarcome | n2=condensante | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
craniopharyngiome
n1=Ostéosarcome | n2=craniopharyngiome | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:« osteogenic » sarcoma
n1=Ostéosarcome | n2=en:« osteogenic » sarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:abdominal tumors (immunodeficiency-associated form)
n1=Ostéosarcome | n2=en:abdominal tumors (immunodeficiency-associated form) | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:accelerated neoplasm growth
n1=Ostéosarcome | n2=en:accelerated neoplasm growth | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:acinar cell carcinoma
n1=Ostéosarcome | n2=en:acinar cell carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:acinar cell neoplasm
n1=Ostéosarcome | n2=en:acinar cell neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:acoustic schwannoma
n1=Ostéosarcome | n2=en:acoustic schwannoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:acral lentiginous melanoma
n1=Ostéosarcome | n2=en:acral lentiginous melanoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:acute leukemia
n1=Ostéosarcome | n2=en:acute leukemia | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:acute lymphoblastic leukemia
n1=Ostéosarcome | n2=en:acute lymphoblastic leukemia | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:acute lymphoblastic leukemia (in 1 patient)
n1=Ostéosarcome | n2=en:acute lymphoblastic leukemia (in 1 patient) | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:acute megakaryoblastic leukemia
n1=Ostéosarcome | n2=en:acute megakaryoblastic leukemia | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:acute monocytic leukemia
n1=Ostéosarcome | n2=en:acute monocytic leukemia | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:acute myeloid leukemia
n1=Ostéosarcome | n2=en:acute myeloid leukemia | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:adamantinoma
n1=Ostéosarcome | n2=en:adamantinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:adenocarcinoma
n1=Ostéosarcome | n2=en:adenocarcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:adenocarcinoma (some)
n1=Ostéosarcome | n2=en:adenocarcinoma (some) | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:adenocarcinoma in adenomatous polyp
n1=Ostéosarcome | n2=en:adenocarcinoma in adenomatous polyp | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:adenocarcinoma in villous adenoma
n1=Ostéosarcome | n2=en:adenocarcinoma in villous adenoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:adenoid cystic carcinoma
n1=Ostéosarcome | n2=en:adenoid cystic carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:adenomyoepithelioma with carcinoma
n1=Ostéosarcome | n2=en:adenomyoepithelioma with carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:adenosarcoma
n1=Ostéosarcome | n2=en:adenosarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:adenosquamous carcinoma
n1=Ostéosarcome | n2=en:adenosquamous carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:adnexal and/or skin appendage neoplasm
n1=Ostéosarcome | n2=en:adnexal and/or skin appendage neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:adnexal carcinoma
n1=Ostéosarcome | n2=en:adnexal carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:adrenal cortex carcinoma
n1=Ostéosarcome | n2=en:adrenal cortex carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:adrenal gland pheochromocytoma
n1=Ostéosarcome | n2=en:adrenal gland pheochromocytoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:adrenal glands are most common site
n1=Ostéosarcome | n2=en:adrenal glands are most common site | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:adult brain neoplasm
n1=Ostéosarcome | n2=en:adult brain neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:adult liver carcinoma
n1=Ostéosarcome | n2=en:adult liver carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:adult soft tissue sarcoma
n1=Ostéosarcome | n2=en:adult soft tissue sarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:adult solid neoplasm
n1=Ostéosarcome | n2=en:adult solid neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:adult undifferentiated high grade pleomorphic sarcoma of bone
n1=Ostéosarcome | n2=en:adult undifferentiated high grade pleomorphic sarcoma of bone | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:aggressive osteoblastoma
n1=Ostéosarcome | n2=en:aggressive osteoblastoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:alpha heavy chain disease
n1=Ostéosarcome | n2=en:alpha heavy chain disease | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:alveolar cell carcinoma (some)
n1=Ostéosarcome | n2=en:alveolar cell carcinoma (some) | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:alveolar rhabdomyosarcoma
n1=Ostéosarcome | n2=en:alveolar rhabdomyosarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:alveolar soft part sarcoma
n1=Ostéosarcome | n2=en:alveolar soft part sarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:amelanotic melanoma
n1=Ostéosarcome | n2=en:amelanotic melanoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:ameloblastic fibrosarcoma
n1=Ostéosarcome | n2=en:ameloblastic fibrosarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:ameloblastic odontosarcoma
n1=Ostéosarcome | n2=en:ameloblastic odontosarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:ampulla of vater adenocarcinoma
n1=Ostéosarcome | n2=en:ampulla of vater adenocarcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:anal canal cloacogenic carcinoma
n1=Ostéosarcome | n2=en:anal canal cloacogenic carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:anal carcinoma
n1=Ostéosarcome | n2=en:anal carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:anaplastic (malignant) meningioma
n1=Ostéosarcome | n2=en:anaplastic (malignant) meningioma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:anaplastic ganglioglioma
n1=Ostéosarcome | n2=en:anaplastic ganglioglioma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:anaplastic osteosarcoma localized
n1=Ostéosarcome | n2=en:anaplastic osteosarcoma localized | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:aneurysmal bone cyst
n1=Ostéosarcome | n2=en:aneurysmal bone cyst | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:angiolipoma
n1=Ostéosarcome | n2=en:angiolipoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:angiomyoliposarcoma
n1=Ostéosarcome | n2=en:angiomyoliposarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:angiomyosarcoma
n1=Ostéosarcome | n2=en:angiomyosarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:angiosarcoma
n1=Ostéosarcome | n2=en:angiosarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:aplastic anemia
n1=Ostéosarcome | n2=en:aplastic anemia | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:appendix carcinoma
n1=Ostéosarcome | n2=en:appendix carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:approximately 10% of cases are paraneoplastic
n1=Ostéosarcome | n2=en:approximately 10% of cases are paraneoplastic | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:askin tumor
n1=Ostéosarcome | n2=en:askin tumor | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:aspects of mortality statistics
n1=Ostéosarcome | n2=en:aspects of mortality statistics | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:aspects of radionuclide imaging
n1=Ostéosarcome | n2=en:aspects of radionuclide imaging | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:associated with other malignancies
n1=Ostéosarcome | n2=en:associated with other malignancies | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:astrocytoma
n1=Ostéosarcome | n2=en:astrocytoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:atypical cartilaginous tumor
n1=Ostéosarcome | n2=en:atypical cartilaginous tumor | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:atypical medullary carcinoma
n1=Ostéosarcome | n2=en:atypical medullary carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:atypical teratoid/rhabdoid tumor
n1=Ostéosarcome | n2=en:atypical teratoid/rhabdoid tumor | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:avian leukosis/sarcoma
n1=Ostéosarcome | n2=en:avian leukosis/sarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:b-cell lymphomas
n1=Ostéosarcome | n2=en:b-cell lymphomas | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:b-cell non-hodgkin lymphoma
n1=Ostéosarcome | n2=en:b-cell non-hodgkin lymphoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:balloon cell melanoma
n1=Ostéosarcome | n2=en:balloon cell melanoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:basal cell nevus
n1=Ostéosarcome | n2=en:basal cell nevus | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:basaloid carcinoma
n1=Ostéosarcome | n2=en:basaloid carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:basocellular neoplasms
n1=Ostéosarcome | n2=en:basocellular neoplasms | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:basocellular neoplasms develop after second decade
n1=Ostéosarcome | n2=en:basocellular neoplasms develop after second decade | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:benign digestive system neoplasm
n1=Ostéosarcome | n2=en:benign digestive system neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:benign endocrine neoplasm
n1=Ostéosarcome | n2=en:benign endocrine neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:benign female reproductive system neoplasm
n1=Ostéosarcome | n2=en:benign female reproductive system neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:benign genitourinary tract neoplasm
n1=Ostéosarcome | n2=en:benign genitourinary tract neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:benign male reproductive system neoplasm
n1=Ostéosarcome | n2=en:benign male reproductive system neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:benign neoplasm
n1=Ostéosarcome | n2=en:benign neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:benign nervous system neoplasm
n1=Ostéosarcome | n2=en:benign nervous system neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:benign osteogenic neoplasm
n1=Ostéosarcome | n2=en:benign osteogenic neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:benign skin neoplasm
n1=Ostéosarcome | n2=en:benign skin neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:benign soft tissue neoplasm
n1=Ostéosarcome | n2=en:benign soft tissue neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:benign teratoma
n1=Ostéosarcome | n2=en:benign teratoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:benign tumors of the eye, heart, and lungs
n1=Ostéosarcome | n2=en:benign tumors of the eye, heart, and lungs | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:biphasic mesothelioma
n1=Ostéosarcome | n2=en:biphasic mesothelioma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:bizarre parosteal osteochondromatous proliferation
n1=Ostéosarcome | n2=en:bizarre parosteal osteochondromatous proliferation | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:bladder carcinoma
n1=Ostéosarcome | n2=en:bladder carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:bladder neoplasm
n1=Ostéosarcome | n2=en:bladder neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:bladder urothelial carcinoma
n1=Ostéosarcome | n2=en:bladder urothelial carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:blood supply aspects
n1=Ostéosarcome | n2=en:blood supply aspects | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:blood vessel neoplasm
n1=Ostéosarcome | n2=en:blood vessel neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:bone angiosarcoma
n1=Ostéosarcome | n2=en:bone angiosarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:bone fibrosarcoma
n1=Ostéosarcome | n2=en:bone fibrosarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:bone leiomyosarcoma
n1=Ostéosarcome | n2=en:bone leiomyosarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:bone liposarcoma
n1=Ostéosarcome | n2=en:bone liposarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:bone neoplasm
n1=Ostéosarcome | n2=en:bone neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:bone osteosarcoma
n1=Ostéosarcome | n2=en:bone osteosarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:bone sarcoma
n1=Ostéosarcome | n2=en:bone sarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:bone-forming neoplasm
n1=Ostéosarcome | n2=en:bone-forming neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:brain neoplasm
n1=Ostéosarcome | n2=en:brain neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:breast cancer (rare)
n1=Ostéosarcome | n2=en:breast cancer (rare) | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:breast cancer, early-onset (in some patients)
n1=Ostéosarcome | n2=en:breast cancer, early-onset (in some patients) | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:breast cancer, lobular
n1=Ostéosarcome | n2=en:breast cancer, lobular | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:breast carcinoma
n1=Ostéosarcome | n2=en:breast carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:breast neoplasm
n1=Ostéosarcome | n2=en:breast neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:breast neoplasms benign (incl nipple)
n1=Ostéosarcome | n2=en:breast neoplasms benign (incl nipple) | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:breast neoplasms malignant and unspecified (incl nipple)
n1=Ostéosarcome | n2=en:breast neoplasms malignant and unspecified (incl nipple) | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:breast sarcoma
n1=Ostéosarcome | n2=en:breast sarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:bronchogenic carcinoma (some)
n1=Ostéosarcome | n2=en:bronchogenic carcinoma (some) | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:burkitt leukemia
n1=Ostéosarcome | n2=en:burkitt leukemia | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:burkitt lymphoma (b-cell lymphoma)
n1=Ostéosarcome | n2=en:burkitt lymphoma (b-cell lymphoma) | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:carcinofibroma
n1=Ostéosarcome | n2=en:carcinofibroma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:carcinoid tumor
n1=Ostéosarcome | n2=en:carcinoid tumor | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:carcinoma
n1=Ostéosarcome | n2=en:carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:carcinoma ex pleomorphic adenoma
n1=Ostéosarcome | n2=en:carcinoma ex pleomorphic adenoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:carcinoma in situ
n1=Ostéosarcome | n2=en:carcinoma in situ | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:carcinoma of bone, connective tissue, skin and breast
n1=Ostéosarcome | n2=en:carcinoma of bone, connective tissue, skin and breast | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:carcinoma of lip, oral cavity and pharynx
n1=Ostéosarcome | n2=en:carcinoma of lip, oral cavity and pharynx | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:carcinoma of unknown primary origin
n1=Ostéosarcome | n2=en:carcinoma of unknown primary origin | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:carcinoma with osteoclast-like giant cells
n1=Ostéosarcome | n2=en:carcinoma with osteoclast-like giant cells | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:carcinoma with pleomorphic, sarcomatoid or sarcomatous elements
n1=Ostéosarcome | n2=en:carcinoma with pleomorphic, sarcomatoid or sarcomatous elements | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:carcinosarcoma
n1=Ostéosarcome | n2=en:carcinosarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:carcinosarcoma, embryonal
n1=Ostéosarcome | n2=en:carcinosarcoma, embryonal | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:carotid body paraganglioma
n1=Ostéosarcome | n2=en:carotid body paraganglioma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:carotid body tumors (most common location)
n1=Ostéosarcome | n2=en:carotid body tumors (most common location) | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:carotid body tumors (most common)
n1=Ostéosarcome | n2=en:carotid body tumors (most common) | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:cartilage-forming neoplasm
n1=Ostéosarcome | n2=en:cartilage-forming neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:cdisc send terminology
n1=Ostéosarcome | n2=en:cdisc send terminology | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:cdisc send tumor findings results terminology
n1=Ostéosarcome | n2=en:cdisc send tumor findings results terminology | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:cellular diagnosis, osteosarcoma
n1=Ostéosarcome | n2=en:cellular diagnosis, osteosarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:cellular secretion
n1=Ostéosarcome | n2=en:cellular secretion | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:cellular tumor antigen p53
n1=Ostéosarcome | n2=en:cellular tumor antigen p53 | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:central nervous system lymphoma
n1=Ostéosarcome | n2=en:central nervous system lymphoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:central osteosarcoma of the mouse skeletal system
n1=Ostéosarcome | n2=en:central osteosarcoma of the mouse skeletal system | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:cerebellar sarcoma
n1=Ostéosarcome | n2=en:cerebellar sarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:cervical cancer (rare)
n1=Ostéosarcome | n2=en:cervical cancer (rare) | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:cervical carcinoma
n1=Ostéosarcome | n2=en:cervical carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:chemical aspects
n1=Ostéosarcome | n2=en:chemical aspects | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:chemically induced
n1=Ostéosarcome | n2=en:chemically induced | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:chief cell adenocarcinoma
n1=Ostéosarcome | n2=en:chief cell adenocarcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:childhood acute lymphoblastic leukemia
n1=Ostéosarcome | n2=en:childhood acute lymphoblastic leukemia | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:childhood acute myeloid leukemia/other myeloid malignancies
n1=Ostéosarcome | n2=en:childhood acute myeloid leukemia/other myeloid malignancies | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:childhood brain neoplasm
n1=Ostéosarcome | n2=en:childhood brain neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:childhood extraocular retinoblastoma
n1=Ostéosarcome | n2=en:childhood extraocular retinoblastoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:childhood fibrosarcoma
n1=Ostéosarcome | n2=en:childhood fibrosarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:childhood ganglioneuroblastoma
n1=Ostéosarcome | n2=en:childhood ganglioneuroblastoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:childhood germ cell tumor
n1=Ostéosarcome | n2=en:childhood germ cell tumor | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:childhood hodgkin lymphoma
n1=Ostéosarcome | n2=en:childhood hodgkin lymphoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:childhood intraocular retinoblastoma
n1=Ostéosarcome | n2=en:childhood intraocular retinoblastoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:childhood langerhans cell histiocytosis
n1=Ostéosarcome | n2=en:childhood langerhans cell histiocytosis | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:childhood leukemia
n1=Ostéosarcome | n2=en:childhood leukemia | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:childhood liposarcoma
n1=Ostéosarcome | n2=en:childhood liposarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:childhood lymphoma
n1=Ostéosarcome | n2=en:childhood lymphoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:childhood malignant kidney neoplasm
n1=Ostéosarcome | n2=en:childhood malignant kidney neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:childhood malignant liver neoplasm
n1=Ostéosarcome | n2=en:childhood malignant liver neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:childhood malignant neoplasm
n1=Ostéosarcome | n2=en:childhood malignant neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:childhood malignant peripheral nerve sheath tumor
n1=Ostéosarcome | n2=en:childhood malignant peripheral nerve sheath tumor | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:childhood myxoid chondrosarcoma
n1=Ostéosarcome | n2=en:childhood myxoid chondrosarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:childhood neuroblastoma
n1=Ostéosarcome | n2=en:childhood neuroblastoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:childhood non-hodgkin lymphoma
n1=Ostéosarcome | n2=en:childhood non-hodgkin lymphoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:childhood osteosarcoma
n1=Ostéosarcome | n2=en:childhood osteosarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:childhood rhabdomyosarcoma
n1=Ostéosarcome | n2=en:childhood rhabdomyosarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:childhood soft tissue sarcoma
n1=Ostéosarcome | n2=en:childhood soft tissue sarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:childhood solid neoplasm
n1=Ostéosarcome | n2=en:childhood solid neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:childhood t lymphoblastic leukemia/lymphoma
n1=Ostéosarcome | n2=en:childhood t lymphoblastic leukemia/lymphoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:childhood undifferentiated high grade pleomorphic sarcoma of bone
n1=Ostéosarcome | n2=en:childhood undifferentiated high grade pleomorphic sarcoma of bone | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:childhood vascular neoplasm
n1=Ostéosarcome | n2=en:childhood vascular neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:chondroblastic osteosarcoma
n1=Ostéosarcome | n2=en:chondroblastic osteosarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:chondroblastic osteosarcoma of the mouse skeletal system
n1=Ostéosarcome | n2=en:chondroblastic osteosarcoma of the mouse skeletal system | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:chondroblastoma
n1=Ostéosarcome | n2=en:chondroblastoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:chondroblastoma, malignant
n1=Ostéosarcome | n2=en:chondroblastoma, malignant | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:chondrogenic neoplasm
n1=Ostéosarcome | n2=en:chondrogenic neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:chondroid chordoma
n1=Ostéosarcome | n2=en:chondroid chordoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:chondroma
n1=Ostéosarcome | n2=en:chondroma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:chondromatosis
n1=Ostéosarcome | n2=en:chondromatosis | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:chondromyxoid fibroma
n1=Ostéosarcome | n2=en:chondromyxoid fibroma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:chondrosarcoma
n1=Ostéosarcome | n2=en:chondrosarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:chondrosarcoma - category
n1=Ostéosarcome | n2=en:chondrosarcoma - category | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:chondrosarcoma of bone
n1=Ostéosarcome | n2=en:chondrosarcoma of bone | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:chondrosarcomatous osteosarcoma localized
n1=Ostéosarcome | n2=en:chondrosarcomatous osteosarcoma localized | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:chordoma
n1=Ostéosarcome | n2=en:chordoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:choriocarcinoma combined with other germ cell elements
n1=Ostéosarcome | n2=en:choriocarcinoma combined with other germ cell elements | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:choroid plexus carcinoma
n1=Ostéosarcome | n2=en:choroid plexus carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:chromaffin cell neoplasm
n1=Ostéosarcome | n2=en:chromaffin cell neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:chronic lymphocytic leukemia
n1=Ostéosarcome | n2=en:chronic lymphocytic leukemia | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:chronic lymphocytic leukemia, b-cell, susceptibility to
n1=Ostéosarcome | n2=en:chronic lymphocytic leukemia, b-cell, susceptibility to | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:chronic myelomonocytic leukemia
n1=Ostéosarcome | n2=en:chronic myelomonocytic leukemia | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:classic kaposi sarcoma
n1=Ostéosarcome | n2=en:classic kaposi sarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:clear cell acanthoma
n1=Ostéosarcome | n2=en:clear cell acanthoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:clear cell chondrosarcoma
n1=Ostéosarcome | n2=en:clear cell chondrosarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:clear cell neoplasm
n1=Ostéosarcome | n2=en:clear cell neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:clear cell renal cell carcinoma
n1=Ostéosarcome | n2=en:clear cell renal cell carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:clear cell sarcoma of soft tissue
n1=Ostéosarcome | n2=en:clear cell sarcoma of soft tissue | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:clear cell sarcoma of the kidney
n1=Ostéosarcome | n2=en:clear cell sarcoma of the kidney | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:clinical data interchange standards consortium terminology
n1=Ostéosarcome | n2=en:clinical data interchange standards consortium terminology | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:codman triangle
n1=Ostéosarcome | n2=en:codman triangle | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:coiled tube sign
n1=Ostéosarcome | n2=en:coiled tube sign | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:colon adenocarcinoma
n1=Ostéosarcome | n2=en:colon adenocarcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:colon carcinoma
n1=Ostéosarcome | n2=en:colon carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:colorectal cancer (in some patients)
n1=Ostéosarcome | n2=en:colorectal cancer (in some patients) | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:colorectal cancer, early onset
n1=Ostéosarcome | n2=en:colorectal cancer, early onset | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:colorectal carcinoma
n1=Ostéosarcome | n2=en:colorectal carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:combined small cell lung carcinoma
n1=Ostéosarcome | n2=en:combined small cell lung carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:complex mixed and/or stromal neoplasm
n1=Ostéosarcome | n2=en:complex mixed and/or stromal neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:complication aspects
n1=Ostéosarcome | n2=en:complication aspects | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:composite hodgkin and non-hodgkin lymphoma
n1=Ostéosarcome | n2=en:composite hodgkin and non-hodgkin lymphoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:congenital mesh qualifier
n1=Ostéosarcome | n2=en:congenital mesh qualifier | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:congenital mesoblastic nephroma
n1=Ostéosarcome | n2=en:congenital mesoblastic nephroma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:connective and soft tissue
n1=Ostéosarcome | n2=en:connective and soft tissue | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:connective and soft tissue cell
n1=Ostéosarcome | n2=en:connective and soft tissue cell | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:conventional osteosarcoma
n1=Ostéosarcome | n2=en:conventional osteosarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:craniopharyngioma
n1=Ostéosarcome | n2=en:craniopharyngioma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:ctdsp2 gene
n1=Ostéosarcome | n2=en:ctdsp2 gene | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:ctdsp2 wt allele
n1=Ostéosarcome | n2=en:ctdsp2 wt allele | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:ctrp terminology
n1=Ostéosarcome | n2=en:ctrp terminology | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:cutaneous leiomyosarcoma (less common)
n1=Ostéosarcome | n2=en:cutaneous leiomyosarcoma (less common) | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:cutaneous melanoma
n1=Ostéosarcome | n2=en:cutaneous melanoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:cylindromas may show malignant transformation
n1=Ostéosarcome | n2=en:cylindromas may show malignant transformation | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:cyst
n1=Ostéosarcome | n2=en:cyst | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:cystadenoma
n1=Ostéosarcome | n2=en:cystadenoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:cystic partially differentiated nephroblastoma
n1=Ostéosarcome | n2=en:cystic partially differentiated nephroblastoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:cystic, mucinous and/or serous neoplasm
n1=Ostéosarcome | n2=en:cystic, mucinous and/or serous neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:dedifferentiated chondrosarcoma
n1=Ostéosarcome | n2=en:dedifferentiated chondrosarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:dedifferentiated chordoma
n1=Ostéosarcome | n2=en:dedifferentiated chordoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:dedifferentiated liposarcoma
n1=Ostéosarcome | n2=en:dedifferentiated liposarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:dermatofibrosarcoma protuberans
n1=Ostéosarcome | n2=en:dermatofibrosarcoma protuberans | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:desmoid-type fibromatosis
n1=Ostéosarcome | n2=en:desmoid-type fibromatosis | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:desmoplastic melanoma
n1=Ostéosarcome | n2=en:desmoplastic melanoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:desmoplastic mesothelioma
n1=Ostéosarcome | n2=en:desmoplastic mesothelioma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:desmoplastic small cell tumor
n1=Ostéosarcome | n2=en:desmoplastic small cell tumor | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:desmoplastic small round cell tumor
n1=Ostéosarcome | n2=en:desmoplastic small round cell tumor | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:development of tumors in adulthood
n1=Ostéosarcome | n2=en:development of tumors in adulthood | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:diagnosis aspect
n1=Ostéosarcome | n2=en:diagnosis aspect | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:diamond-blackfan anemia 1
n1=Ostéosarcome | n2=en:diamond-blackfan anemia 1 | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:diffuse embryoma
n1=Ostéosarcome | n2=en:diffuse embryoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:digestive system carcinoma
n1=Ostéosarcome | n2=en:digestive system carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:digestive system neoplasms
n1=Ostéosarcome | n2=en:digestive system neoplasms | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:digestive system neuroendocrine tumor g1
n1=Ostéosarcome | n2=en:digestive system neuroendocrine tumor g1 | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:digital papillary eccrine carcinoma
n1=Ostéosarcome | n2=en:digital papillary eccrine carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:duct carcinoma, desmoplastic type
n1=Ostéosarcome | n2=en:duct carcinoma, desmoplastic type | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:ductal breast carcinoma
n1=Ostéosarcome | n2=en:ductal breast carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:ductal carcinoma
n1=Ostéosarcome | n2=en:ductal carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:ductal, lobular and/or medullary neoplasm
n1=Ostéosarcome | n2=en:ductal, lobular and/or medullary neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:duodenal carcinoid
n1=Ostéosarcome | n2=en:duodenal carcinoid | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:duodenal carcinoma
n1=Ostéosarcome | n2=en:duodenal carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:dysgerminoma
n1=Ostéosarcome | n2=en:dysgerminoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:dysplasia with neoplasia
n1=Ostéosarcome | n2=en:dysplasia with neoplasia | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:early-onset hepatocellular carcinoma
n1=Ostéosarcome | n2=en:early-onset hepatocellular carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:ebv-induced b-cell lymphoma
n1=Ostéosarcome | n2=en:ebv-induced b-cell lymphoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:eccrine adenocarcinoma
n1=Ostéosarcome | n2=en:eccrine adenocarcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:eccrine porocarcinoma
n1=Ostéosarcome | n2=en:eccrine porocarcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:ectomesenchymoma
n1=Ostéosarcome | n2=en:ectomesenchymoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:embryologic
n1=Ostéosarcome | n2=en:embryologic | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:embryonal carcinoma
n1=Ostéosarcome | n2=en:embryonal carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:embryonal neoplasm
n1=Ostéosarcome | n2=en:embryonal neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:embryonal rhabdomyosarcoma
n1=Ostéosarcome | n2=en:embryonal rhabdomyosarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:embryonal tumor with multilayered rosettes, c19mc-altered
n1=Ostéosarcome | n2=en:embryonal tumor with multilayered rosettes, c19mc-altered | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:encapsulated papillary carcinoma with invasion
n1=Ostéosarcome | n2=en:encapsulated papillary carcinoma with invasion | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:enchondroma
n1=Ostéosarcome | n2=en:enchondroma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:endocrine neoplasms malignant and unspecified
n1=Ostéosarcome | n2=en:endocrine neoplasms malignant and unspecified | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:endolymphatic sac tumor
n1=Ostéosarcome | n2=en:endolymphatic sac tumor | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:endometrial adenocarcinoma
n1=Ostéosarcome | n2=en:endometrial adenocarcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:endometrial carcinoma
n1=Ostéosarcome | n2=en:endometrial carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:endometrial stromal sarcoma - category
n1=Ostéosarcome | n2=en:endometrial stromal sarcoma - category | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:endometrial stromal tumors
n1=Ostéosarcome | n2=en:endometrial stromal tumors | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:enostosis
n1=Ostéosarcome | n2=en:enostosis | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:enteropathy-associated t-cell lymphoma
n1=Ostéosarcome | n2=en:enteropathy-associated t-cell lymphoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:enzymology
n1=Ostéosarcome | n2=en:enzymology | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:ependymoma
n1=Ostéosarcome | n2=en:ependymoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:epidemiologic
n1=Ostéosarcome | n2=en:epidemiologic | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:epithelial cell
n1=Ostéosarcome | n2=en:epithelial cell | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:epithelial neoplasm
n1=Ostéosarcome | n2=en:epithelial neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:epithelial tissue
n1=Ostéosarcome | n2=en:epithelial tissue | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:epithelial-myoepithelial carcinoma
n1=Ostéosarcome | n2=en:epithelial-myoepithelial carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:epithelioid cell melanoma
n1=Ostéosarcome | n2=en:epithelioid cell melanoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:epithelioid leiomyosarcoma
n1=Ostéosarcome | n2=en:epithelioid leiomyosarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:epithelioid malignant peripheral nerve sheath tumor
n1=Ostéosarcome | n2=en:epithelioid malignant peripheral nerve sheath tumor | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:epithelioid mesothelioma
n1=Ostéosarcome | n2=en:epithelioid mesothelioma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:epithelioid sarcoma
n1=Ostéosarcome | n2=en:epithelioid sarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:epithelioid trophoblastic tumor
n1=Ostéosarcome | n2=en:epithelioid trophoblastic tumor | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:esophageal carcinoma
n1=Ostéosarcome | n2=en:esophageal carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:essential thrombocythemia
n1=Ostéosarcome | n2=en:essential thrombocythemia | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:esthesioneurocytoma
n1=Ostéosarcome | n2=en:esthesioneurocytoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:ethnologic
n1=Ostéosarcome | n2=en:ethnologic | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:etiology aspects
n1=Ostéosarcome | n2=en:etiology aspects | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:ewing sarcoma
n1=Ostéosarcome | n2=en:ewing sarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:ewing sarcoma of bone
n1=Ostéosarcome | n2=en:ewing sarcoma of bone | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:ewing sarcoma/peripheral primitive neuroectodermal tumor
n1=Ostéosarcome | n2=en:ewing sarcoma/peripheral primitive neuroectodermal tumor | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:exostosis
n1=Ostéosarcome | n2=en:exostosis | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:exposure as collected domain
n1=Ostéosarcome | n2=en:exposure as collected domain | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:extra-adrenal paraganglioma
n1=Ostéosarcome | n2=en:extra-adrenal paraganglioma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:extra-adrenal sympathetic paraganglioma
n1=Ostéosarcome | n2=en:extra-adrenal sympathetic paraganglioma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:extrahepatic bile duct carcinoma
n1=Ostéosarcome | n2=en:extrahepatic bile duct carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:extramammary paget disease
n1=Ostéosarcome | n2=en:extramammary paget disease | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:extrarenal rhabdoid tumor
n1=Ostéosarcome | n2=en:extrarenal rhabdoid tumor | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:extraskeletal chondrosarcoma metastatic
n1=Ostéosarcome | n2=en:extraskeletal chondrosarcoma metastatic | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:extraskeletal chondrosarcoma recurrent
n1=Ostéosarcome | n2=en:extraskeletal chondrosarcoma recurrent | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:extraskeletal ewing sarcoma
n1=Ostéosarcome | n2=en:extraskeletal ewing sarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:extraskeletal myxoid chondrosarcoma
n1=Ostéosarcome | n2=en:extraskeletal myxoid chondrosarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:extraskeletal osteosarcoma
n1=Ostéosarcome | n2=en:extraskeletal osteosarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:eye neoplasm
n1=Ostéosarcome | n2=en:eye neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:fallopian tube carcinoma
n1=Ostéosarcome | n2=en:fallopian tube carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:familial letterer-siwe disease
n1=Ostéosarcome | n2=en:familial letterer-siwe disease | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:fascial fibrosarcoma
n1=Ostéosarcome | n2=en:fascial fibrosarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:female breast carcinoma
n1=Ostéosarcome | n2=en:female breast carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:fibro-osteoma morphology
n1=Ostéosarcome | n2=en:fibro-osteoma morphology | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:fibroblastic liposarcoma
n1=Ostéosarcome | n2=en:fibroblastic liposarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:fibroblastic osteosarcoma
n1=Ostéosarcome | n2=en:fibroblastic osteosarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:fibroblastic osteosarcoma of the mouse skeletal system
n1=Ostéosarcome | n2=en:fibroblastic osteosarcoma of the mouse skeletal system | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:fibroelastoma
n1=Ostéosarcome | n2=en:fibroelastoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:fibroepithelial neoplasm
n1=Ostéosarcome | n2=en:fibroepithelial neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:fibrohistiocytic neoplasm
n1=Ostéosarcome | n2=en:fibrohistiocytic neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:fibroma
n1=Ostéosarcome | n2=en:fibroma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:fibrosarcoma
n1=Ostéosarcome | n2=en:fibrosarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:fibrosarcoma of connective tissue
n1=Ostéosarcome | n2=en:fibrosarcoma of connective tissue | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:fibrosarcoma of spleen
n1=Ostéosarcome | n2=en:fibrosarcoma of spleen | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:fibrous connective tissue neoplasm
n1=Ostéosarcome | n2=en:fibrous connective tissue neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:fibrous dysplasia
n1=Ostéosarcome | n2=en:fibrous dysplasia | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:fluid-fluid level
n1=Ostéosarcome | n2=en:fluid-fluid level | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:follicular dendritic cell sarcoma
n1=Ostéosarcome | n2=en:follicular dendritic cell sarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:follicular dendritic sarcoma of intraabdominal lymph node
n1=Ostéosarcome | n2=en:follicular dendritic sarcoma of intraabdominal lymph node | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:follicular dendritic sarcoma of lymph nodes of multiple sites
n1=Ostéosarcome | n2=en:follicular dendritic sarcoma of lymph nodes of multiple sites | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:follicular lymphoma
n1=Ostéosarcome | n2=en:follicular lymphoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:follicular neoplasm
n1=Ostéosarcome | n2=en:follicular neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:frequent skin cancer
n1=Ostéosarcome | n2=en:frequent skin cancer | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:gallbladder carcinoma
n1=Ostéosarcome | n2=en:gallbladder carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:ganglioneuroblastoma
n1=Ostéosarcome | n2=en:ganglioneuroblastoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:ganglioneuroma
n1=Ostéosarcome | n2=en:ganglioneuroma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:gastric adenocarcinoma
n1=Ostéosarcome | n2=en:gastric adenocarcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:gastric cancer, diffuse type, poorly differentiated, high-grade submucosal lesions
n1=Ostéosarcome | n2=en:gastric cancer, diffuse type, poorly differentiated, high-grade submucosal lesions | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:gastric carcinoma
n1=Ostéosarcome | n2=en:gastric carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:gastrointestinal neoplasms malignant and unspecified
n1=Ostéosarcome | n2=en:gastrointestinal neoplasms malignant and unspecified | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:gastrointestinal stromal tumor
n1=Ostéosarcome | n2=en:gastrointestinal stromal tumor | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:gastrointestinal stromal tumors (less common)
n1=Ostéosarcome | n2=en:gastrointestinal stromal tumors (less common) | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:genetic aspects
n1=Ostéosarcome | n2=en:genetic aspects | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:germ cell tumor
n1=Ostéosarcome | n2=en:germ cell tumor | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:germinoma
n1=Ostéosarcome | n2=en:germinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:gestational trophoblastic tumor
n1=Ostéosarcome | n2=en:gestational trophoblastic tumor | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:giant cell astrocytoma
n1=Ostéosarcome | n2=en:giant cell astrocytoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:giant cell lesion of small bones
n1=Ostéosarcome | n2=en:giant cell lesion of small bones | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:giant cell sarcoma
n1=Ostéosarcome | n2=en:giant cell sarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:giant cell sarcoma (except of bone, m-92503)
n1=Ostéosarcome | n2=en:giant cell sarcoma (except of bone, m-92503) | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:giant cell tumor
n1=Ostéosarcome | n2=en:giant cell tumor | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:giant cell tumor of bone
n1=Ostéosarcome | n2=en:giant cell tumor of bone | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:glassy cell carcinoma
n1=Ostéosarcome | n2=en:glassy cell carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:glioblastoma
n1=Ostéosarcome | n2=en:glioblastoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:glioma
n1=Ostéosarcome | n2=en:glioma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:gliosarcoma
n1=Ostéosarcome | n2=en:gliosarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:glomus tympanicum paraganglioma
n1=Ostéosarcome | n2=en:glomus tympanicum paraganglioma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:gnathic osteosarcoma
n1=Ostéosarcome | n2=en:gnathic osteosarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:gonadoblastoma
n1=Ostéosarcome | n2=en:gonadoblastoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:granular cell tumor and/or alveolar soft part sarcoma
n1=Ostéosarcome | n2=en:granular cell tumor and/or alveolar soft part sarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:granulocytic sarcoma
n1=Ostéosarcome | n2=en:granulocytic sarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:growth hormone-producing pituitary gland neoplasm
n1=Ostéosarcome | n2=en:growth hormone-producing pituitary gland neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:haematopoietic neoplasms (excl leukaemias and lymphomas)
n1=Ostéosarcome | n2=en:haematopoietic neoplasms (excl leukaemias and lymphomas) | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:hamartoma
n1=Ostéosarcome | n2=en:hamartoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:hardcastle's syndrome
n1=Ostéosarcome | n2=en:hardcastle's syndrome | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:head and neck paraganglioma
n1=Ostéosarcome | n2=en:head and neck paraganglioma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:heavy chain disease
n1=Ostéosarcome | n2=en:heavy chain disease | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:hemangioblastoma, sporadic cerebellar (e.g., 193300.0007)
n1=Ostéosarcome | n2=en:hemangioblastoma, sporadic cerebellar (e.g., 193300.0007) | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:hematopoietic and lymphoid cell neoplasm
n1=Ostéosarcome | n2=en:hematopoietic and lymphoid cell neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:hemophagocytic lymphohistiocytosis
n1=Ostéosarcome | n2=en:hemophagocytic lymphohistiocytosis | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:hemophagocytic lymphohistiocytosis (in some patients)
n1=Ostéosarcome | n2=en:hemophagocytic lymphohistiocytosis (in some patients) | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:hepatic and biliary neoplasms benign
n1=Ostéosarcome | n2=en:hepatic and biliary neoplasms benign | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:hepatobiliary neoplasms malignant and unspecified
n1=Ostéosarcome | n2=en:hepatobiliary neoplasms malignant and unspecified | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:hepatoblastoma
n1=Ostéosarcome | n2=en:hepatoblastoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:hepatoblastoma, ser241phe (allelic variant)
n1=Ostéosarcome | n2=en:hepatoblastoma, ser241phe (allelic variant) | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:hepatoid adenocarcinoma
n1=Ostéosarcome | n2=en:hepatoid adenocarcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:hereditary neoplastic syndrome
n1=Ostéosarcome | n2=en:hereditary neoplastic syndrome | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:hereditary retinoblastoma
n1=Ostéosarcome | n2=en:hereditary retinoblastoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:high grade serous carcinoma
n1=Ostéosarcome | n2=en:high grade serous carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:high grade surface osteosarcoma
n1=Ostéosarcome | n2=en:high grade surface osteosarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:high grade surface osteosarcoma of the mouse skeletal system
n1=Ostéosarcome | n2=en:high grade surface osteosarcoma of the mouse skeletal system | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:high risk gastrointestinal stromal tumor
n1=Ostéosarcome | n2=en:high risk gastrointestinal stromal tumor | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:histiocytic sarcoma
n1=Ostéosarcome | n2=en:histiocytic sarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:historical aspects qualifier
n1=Ostéosarcome | n2=en:historical aspects qualifier | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:hodgkin lymphoma
n1=Ostéosarcome | n2=en:hodgkin lymphoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:hypereosinophilic syndrome
n1=Ostéosarcome | n2=en:hypereosinophilic syndrome | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:hypersensitivity to chemotherapy
n1=Ostéosarcome | n2=en:hypersensitivity to chemotherapy | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:hypopharyngeal carcinoma
n1=Ostéosarcome | n2=en:hypopharyngeal carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:hypothalamic neoplasm
n1=Ostéosarcome | n2=en:hypothalamic neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:idiopathic hypereosinophilic syndrome
n1=Ostéosarcome | n2=en:idiopathic hypereosinophilic syndrome | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:ileal, cecal, ovarian, and breast tumors, occasionally (endemic form)
n1=Ostéosarcome | n2=en:ileal, cecal, ovarian, and breast tumors, occasionally (endemic form) | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:immunology aspects
n1=Ostéosarcome | n2=en:immunology aspects | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:in blood
n1=Ostéosarcome | n2=en:in blood | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:in cerebrospinal fluid
n1=Ostéosarcome | n2=en:in cerebrospinal fluid | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:in situ neoplasm (morphology)
n1=Ostéosarcome | n2=en:in situ neoplasm (morphology) | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:in urine
n1=Ostéosarcome | n2=en:in urine | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:increased hepatocellular carcinoma risk
n1=Ostéosarcome | n2=en:increased hepatocellular carcinoma risk | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:increased incidence of hepatocellular carcinoma
n1=Ostéosarcome | n2=en:increased incidence of hepatocellular carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:increased incidence of rectosigmoid cancer
n1=Ostéosarcome | n2=en:increased incidence of rectosigmoid cancer | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:increased malignancy risk, especially lymphoma and skin neoplasm
n1=Ostéosarcome | n2=en:increased malignancy risk, especially lymphoma and skin neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:increased risk for cancer
n1=Ostéosarcome | n2=en:increased risk for cancer | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:increased risk for embryonal tumors
n1=Ostéosarcome | n2=en:increased risk for embryonal tumors | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:increased risk for hematologic cancer, particularly acute myeloid leukemia
n1=Ostéosarcome | n2=en:increased risk for hematologic cancer, particularly acute myeloid leukemia | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:increased risk for lymphoma hodgkin disease
n1=Ostéosarcome | n2=en:increased risk for lymphoma hodgkin disease | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:increased risk for monoclonal gammopathy
n1=Ostéosarcome | n2=en:increased risk for monoclonal gammopathy | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:increased risk for multiple myeloma
n1=Ostéosarcome | n2=en:increased risk for multiple myeloma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:increased risk for wilms tumor
n1=Ostéosarcome | n2=en:increased risk for wilms tumor | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:increased risk in heterozygotes
n1=Ostéosarcome | n2=en:increased risk in heterozygotes | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:increased risk of breast cancer in women
n1=Ostéosarcome | n2=en:increased risk of breast cancer in women | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:increased risk of chondrosarcoma
n1=Ostéosarcome | n2=en:increased risk of chondrosarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:increased risk of chondrosarcoma (mean age of onset 31 years)
n1=Ostéosarcome | n2=en:increased risk of chondrosarcoma (mean age of onset 31 years) | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:increased risk of gastrointestinal cancer
n1=Ostéosarcome | n2=en:increased risk of gastrointestinal cancer | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:increased risk of hematologic malignancy (1 patient)
n1=Ostéosarcome | n2=en:increased risk of hematologic malignancy (1 patient) | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:increased risk of leukemia
n1=Ostéosarcome | n2=en:increased risk of leukemia | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:increased risk of malignancy
n1=Ostéosarcome | n2=en:increased risk of malignancy | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:increased risk of malignancy (classic feature)
n1=Ostéosarcome | n2=en:increased risk of malignancy (classic feature) | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:increased risk of malignant lymphoma
n1=Ostéosarcome | n2=en:increased risk of malignant lymphoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:increased risk of medulloblastoma (rare)
n1=Ostéosarcome | n2=en:increased risk of medulloblastoma (rare) | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:increased risk of meningioma
n1=Ostéosarcome | n2=en:increased risk of meningioma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:increased risk of myelodysplastic syndrome or leukemia (in some patients)
n1=Ostéosarcome | n2=en:increased risk of myelodysplastic syndrome or leukemia (in some patients) | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:increased risk of myelodysplastic syndromes
n1=Ostéosarcome | n2=en:increased risk of myelodysplastic syndromes | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:increased risk of pancreatic cancer
n1=Ostéosarcome | n2=en:increased risk of pancreatic cancer | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:increased risk of testicular cancer
n1=Ostéosarcome | n2=en:increased risk of testicular cancer | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:increased risk of tumor formation, especially of the head
n1=Ostéosarcome | n2=en:increased risk of tumor formation, especially of the head | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:increased susceptibility to b-cell lymphoma
n1=Ostéosarcome | n2=en:increased susceptibility to b-cell lymphoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:increased susceptibility to cancer
n1=Ostéosarcome | n2=en:increased susceptibility to cancer | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:increased susceptibility to carcinomas, especially cancers related to cutaneous viral infections
n1=Ostéosarcome | n2=en:increased susceptibility to carcinomas, especially cancers related to cutaneous viral infections | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:increased susceptibility to hematologic malignancies
n1=Ostéosarcome | n2=en:increased susceptibility to hematologic malignancies | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:increased susceptibility to large granular lymphocytic t-cell leukemia
n1=Ostéosarcome | n2=en:increased susceptibility to large granular lymphocytic t-cell leukemia | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:index tumor
n1=Ostéosarcome | n2=en:index tumor | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:indolent clinical course
n1=Ostéosarcome | n2=en:indolent clinical course | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:indolent systemic mastocytosis
n1=Ostéosarcome | n2=en:indolent systemic mastocytosis | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:infantile fibrosarcoma
n1=Ostéosarcome | n2=en:infantile fibrosarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:infiltrating carcinoma with ductal and lobular features
n1=Ostéosarcome | n2=en:infiltrating carcinoma with ductal and lobular features | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:infiltrating duct mixed with other types of carcinoma
n1=Ostéosarcome | n2=en:infiltrating duct mixed with other types of carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:infiltrating lobular mixed with other types of carcinoma
n1=Ostéosarcome | n2=en:infiltrating lobular mixed with other types of carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:interdigitating dendritic cell sarcoma
n1=Ostéosarcome | n2=en:interdigitating dendritic cell sarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:intermediate filaments present
n1=Ostéosarcome | n2=en:intermediate filaments present | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:intermediate osteogenic neoplasm
n1=Ostéosarcome | n2=en:intermediate osteogenic neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:intracortical osteosarcoma of the mouse skeletal system
n1=Ostéosarcome | n2=en:intracortical osteosarcoma of the mouse skeletal system | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:intracytoplasmic eosinophilic inclusion
n1=Ostéosarcome | n2=en:intracytoplasmic eosinophilic inclusion | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:intraductal papillary adenocarcinoma with invasion
n1=Ostéosarcome | n2=en:intraductal papillary adenocarcinoma with invasion | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:intraosseous well differentiated osteosarcoma of the mouse skeletal system
n1=Ostéosarcome | n2=en:intraosseous well differentiated osteosarcoma of the mouse skeletal system | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:invasive ductal and lobular carcinoma in situ
n1=Ostéosarcome | n2=en:invasive ductal and lobular carcinoma in situ | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:invasive ductal carcinoma, not otherwise specified
n1=Ostéosarcome | n2=en:invasive ductal carcinoma, not otherwise specified | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:invasive micropapillary breast carcinoma
n1=Ostéosarcome | n2=en:invasive micropapillary breast carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:islet cell tumor
n1=Ostéosarcome | n2=en:islet cell tumor | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:jaw and kidney tumor (endemic form)
n1=Ostéosarcome | n2=en:jaw and kidney tumor (endemic form) | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:jugulotympanic paraganglioma
n1=Ostéosarcome | n2=en:jugulotympanic paraganglioma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:juvenile ovarian granulosa cell tumor
n1=Ostéosarcome | n2=en:juvenile ovarian granulosa cell tumor | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:kaposi sarcoma
n1=Ostéosarcome | n2=en:kaposi sarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:kaposi sarcoma (1 patient)
n1=Ostéosarcome | n2=en:kaposi sarcoma (1 patient) | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:kidney sarcoma
n1=Ostéosarcome | n2=en:kidney sarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:kidney wilms tumor
n1=Ostéosarcome | n2=en:kidney wilms tumor | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:kupffer cell sarcoma
n1=Ostéosarcome | n2=en:kupffer cell sarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:langerhans cell histiocytosis
n1=Ostéosarcome | n2=en:langerhans cell histiocytosis | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:langerhans cell sarcoma
n1=Ostéosarcome | n2=en:langerhans cell sarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:large cell carcinoma
n1=Ostéosarcome | n2=en:large cell carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:large cell lung carcinoma with rhabdoid phenotype
n1=Ostéosarcome | n2=en:large cell lung carcinoma with rhabdoid phenotype | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:large cell neuroendocrine carcinoma
n1=Ostéosarcome | n2=en:large cell neuroendocrine carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:laryngeal carcinoma
n1=Ostéosarcome | n2=en:laryngeal carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:leiomyosarcoma
n1=Ostéosarcome | n2=en:leiomyosarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:lentigo maligna melanoma
n1=Ostéosarcome | n2=en:lentigo maligna melanoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:leukemia
n1=Ostéosarcome | n2=en:leukemia | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:leukemia (both all and aml)
n1=Ostéosarcome | n2=en:leukemia (both all and aml) | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:leukemia (category)
n1=Ostéosarcome | n2=en:leukemia (category) | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:li-fraumeni syndrome
n1=Ostéosarcome | n2=en:li-fraumeni syndrome | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:li-fraumeni syndrome 1
n1=Ostéosarcome | n2=en:li-fraumeni syndrome 1 | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:lip and oral cavity carcinoma
n1=Ostéosarcome | n2=en:lip and oral cavity carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:lipoma
n1=Ostéosarcome | n2=en:lipoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:lipomatous neoplasm
n1=Ostéosarcome | n2=en:lipomatous neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:liposarcoma
n1=Ostéosarcome | n2=en:liposarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:liposarcoma of connective tissue
n1=Ostéosarcome | n2=en:liposarcoma of connective tissue | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:liver carcinoma
n1=Ostéosarcome | n2=en:liver carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:liver sarcoma
n1=Ostéosarcome | n2=en:liver sarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:lobular breast carcinoma
n1=Ostéosarcome | n2=en:lobular breast carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:localized osteosarcoma
n1=Ostéosarcome | n2=en:localized osteosarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:low grade central osteosarcoma
n1=Ostéosarcome | n2=en:low grade central osteosarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:low grade myofibroblastic sarcoma
n1=Ostéosarcome | n2=en:low grade myofibroblastic sarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:low grade serous carcinoma
n1=Ostéosarcome | n2=en:low grade serous carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:low incidence of plexiform neurofibromas
n1=Ostéosarcome | n2=en:low incidence of plexiform neurofibromas | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:low-grade neuroendocrine carcinoma (submandibular glands, salivary glands, maxillary sinus, nasal cavity)
n1=Ostéosarcome | n2=en:low-grade neuroendocrine carcinoma (submandibular glands, salivary glands, maxillary sinus, nasal cavity) | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:lung
n1=Ostéosarcome | n2=en:lung | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:lung adenocarcinoma
n1=Ostéosarcome | n2=en:lung adenocarcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:lung carcinoid tumor
n1=Ostéosarcome | n2=en:lung carcinoid tumor | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:lymphangiosarcoma
n1=Ostéosarcome | n2=en:lymphangiosarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:lymphatic vessel neoplasm
n1=Ostéosarcome | n2=en:lymphatic vessel neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:lymphoma
n1=Ostéosarcome | n2=en:lymphoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:lymphoma (in some patients)
n1=Ostéosarcome | n2=en:lymphoma (in some patients) | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:lymphomas nec
n1=Ostéosarcome | n2=en:lymphomas nec | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:lymphoproliferative disorder
n1=Ostéosarcome | n2=en:lymphoproliferative disorder | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:lymphoproliferative disorder (in some patients)
n1=Ostéosarcome | n2=en:lymphoproliferative disorder (in some patients) | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:lymphosarcoma
n1=Ostéosarcome | n2=en:lymphosarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:lymphosarcoma of lymph nodes of head, face and neck
n1=Ostéosarcome | n2=en:lymphosarcoma of lymph nodes of head, face and neck | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:lymphosarcoma of lymph nodes of multiple sites
n1=Ostéosarcome | n2=en:lymphosarcoma of lymph nodes of multiple sites | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:male germ cell tumors (gct), 2 subtypes -
n1=Ostéosarcome | n2=en:male germ cell tumors (gct), 2 subtypes - | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignancy (34%)
n1=Ostéosarcome | n2=en:malignancy (34%) | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignancy in approximately 10%
n1=Ostéosarcome | n2=en:malignancy in approximately 10% | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignancy in giant cell tumor of bone
n1=Ostéosarcome | n2=en:malignancy in giant cell tumor of bone | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant adrenal gland pheochromocytoma
n1=Ostéosarcome | n2=en:malignant adrenal gland pheochromocytoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant aortic body tumor
n1=Ostéosarcome | n2=en:malignant aortic body tumor | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant blood vessel neoplasm
n1=Ostéosarcome | n2=en:malignant blood vessel neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant bone marrow neoplasm
n1=Ostéosarcome | n2=en:malignant bone marrow neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant bone neoplasm
n1=Ostéosarcome | n2=en:malignant bone neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant breast neoplasm
n1=Ostéosarcome | n2=en:malignant breast neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant carotid body paraganglioma
n1=Ostéosarcome | n2=en:malignant carotid body paraganglioma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant cell
n1=Ostéosarcome | n2=en:malignant cell | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant central nervous system neoplasm
n1=Ostéosarcome | n2=en:malignant central nervous system neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant childhood central nervous system neoplasm
n1=Ostéosarcome | n2=en:malignant childhood central nervous system neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant childhood germ cell tumor
n1=Ostéosarcome | n2=en:malignant childhood germ cell tumor | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant colon neoplasm
n1=Ostéosarcome | n2=en:malignant colon neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant digestive system neoplasm
n1=Ostéosarcome | n2=en:malignant digestive system neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant epithelioma
n1=Ostéosarcome | n2=en:malignant epithelioma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant esophageal neoplasm
n1=Ostéosarcome | n2=en:malignant esophageal neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant extra-adrenal paraganglioma
n1=Ostéosarcome | n2=en:malignant extra-adrenal paraganglioma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant fibrous histiocytoma (in about 35% of patients)
n1=Ostéosarcome | n2=en:malignant fibrous histiocytoma (in about 35% of patients) | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant genitourinary tract tumor
n1=Ostéosarcome | n2=en:malignant genitourinary tract tumor | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant giant cell neoplasm
n1=Ostéosarcome | n2=en:malignant giant cell neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant glioma
n1=Ostéosarcome | n2=en:malignant glioma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant glomus tumor
n1=Ostéosarcome | n2=en:malignant glomus tumor | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant granular cell tumor
n1=Ostéosarcome | n2=en:malignant granular cell tumor | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant granulosa cell tumor
n1=Ostéosarcome | n2=en:malignant granulosa cell tumor | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant histiocytosis
n1=Ostéosarcome | n2=en:malignant histiocytosis | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant immunoproliferative disease (clinical)
n1=Ostéosarcome | n2=en:malignant immunoproliferative disease (clinical) | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant immunoproliferative neoplasm
n1=Ostéosarcome | n2=en:malignant immunoproliferative neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant joint neoplasm
n1=Ostéosarcome | n2=en:malignant joint neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant laryngeal neoplasm
n1=Ostéosarcome | n2=en:malignant laryngeal neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant leydig cell tumor
n1=Ostéosarcome | n2=en:malignant leydig cell tumor | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant mast cell neoplasm
n1=Ostéosarcome | n2=en:malignant mast cell neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant melanoma in giant pigmented nevus
n1=Ostéosarcome | n2=en:malignant melanoma in giant pigmented nevus | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant melanoma in precancerous melanosis
n1=Ostéosarcome | n2=en:malignant melanoma in precancerous melanosis | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant mesenchymoma
n1=Ostéosarcome | n2=en:malignant mesenchymoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant mesenchymoma metastatic
n1=Ostéosarcome | n2=en:malignant mesenchymoma metastatic | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant mesenchymoma recurrent
n1=Ostéosarcome | n2=en:malignant mesenchymoma recurrent | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant mesothelioma
n1=Ostéosarcome | n2=en:malignant mesothelioma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant mixed neoplasm
n1=Ostéosarcome | n2=en:malignant mixed neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant mixed tumor, carcinomatous type
n1=Ostéosarcome | n2=en:malignant mixed tumor, carcinomatous type | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant mixed tumor, chondrosarcomatous type
n1=Ostéosarcome | n2=en:malignant mixed tumor, chondrosarcomatous type | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant mixed tumor, osteosarcomatous type
n1=Ostéosarcome | n2=en:malignant mixed tumor, osteosarcomatous type | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant muscle neoplasm
n1=Ostéosarcome | n2=en:malignant muscle neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant musculoskeletal and connective tissue neoplasms
n1=Ostéosarcome | n2=en:malignant musculoskeletal and connective tissue neoplasms | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant myomatous tumor
n1=Ostéosarcome | n2=en:malignant myomatous tumor | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant neoplasm
n1=Ostéosarcome | n2=en:malignant neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant neoplasm (morphology)
n1=Ostéosarcome | n2=en:malignant neoplasm (morphology) | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant neoplasm musculoskeletal
n1=Ostéosarcome | n2=en:malignant neoplasm musculoskeletal | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant neoplasm of bone, connective tissue, skin and breast
n1=Ostéosarcome | n2=en:malignant neoplasm of bone, connective tissue, skin and breast | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant neoplasm of connective tissue
n1=Ostéosarcome | n2=en:malignant neoplasm of connective tissue | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant neoplasm of digestive organs and peritoneum
n1=Ostéosarcome | n2=en:malignant neoplasm of digestive organs and peritoneum | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant neoplasm of genitourinary organ
n1=Ostéosarcome | n2=en:malignant neoplasm of genitourinary organ | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant neoplasm of lip, oral cavity and pharynx
n1=Ostéosarcome | n2=en:malignant neoplasm of lip, oral cavity and pharynx | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant neoplasm of nail apparatus
n1=Ostéosarcome | n2=en:malignant neoplasm of nail apparatus | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant neoplasm of other and unspecified sites
n1=Ostéosarcome | n2=en:malignant neoplasm of other and unspecified sites | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant neoplasm of skeletal system
n1=Ostéosarcome | n2=en:malignant neoplasm of skeletal system | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant neoplasm, overlapping lesion of digestive system
n1=Ostéosarcome | n2=en:malignant neoplasm, overlapping lesion of digestive system | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant neoplasm, uncertain whether primary or metastatic
n1=Ostéosarcome | n2=en:malignant neoplasm, uncertain whether primary or metastatic | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant neoplasms of respiratory and intrathoracic organs
n1=Ostéosarcome | n2=en:malignant neoplasms of respiratory and intrathoracic organs | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant neuroendocrine neoplasm, epithelial
n1=Ostéosarcome | n2=en:malignant neuroendocrine neoplasm, epithelial | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant neuroendocrine neoplasm, neural
n1=Ostéosarcome | n2=en:malignant neuroendocrine neoplasm, neural | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant neuroendocrine tumor
n1=Ostéosarcome | n2=en:malignant neuroendocrine tumor | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant odontogenic ghost cell tumor
n1=Ostéosarcome | n2=en:malignant odontogenic ghost cell tumor | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant odontogenic neoplasm
n1=Ostéosarcome | n2=en:malignant odontogenic neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant osseous and chondromatous tumor morphology
n1=Ostéosarcome | n2=en:malignant osseous and chondromatous tumor morphology | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant ossifying fibromyxoid tumor
n1=Ostéosarcome | n2=en:malignant ossifying fibromyxoid tumor | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant osteoblast
n1=Ostéosarcome | n2=en:malignant osteoblast | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant ovarian brenner tumor
n1=Ostéosarcome | n2=en:malignant ovarian brenner tumor | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant ovarian epithelial tumor
n1=Ostéosarcome | n2=en:malignant ovarian epithelial tumor | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant ovarian neoplasm
n1=Ostéosarcome | n2=en:malignant ovarian neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant ovarian thecoma
n1=Ostéosarcome | n2=en:malignant ovarian thecoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant pancreatic neoplasm
n1=Ostéosarcome | n2=en:malignant pancreatic neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant pecoma
n1=Ostéosarcome | n2=en:malignant pecoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant peripheral nerve sheath tumor
n1=Ostéosarcome | n2=en:malignant peripheral nerve sheath tumor | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant peripheral nerve sheath tumor with perineurial differentiation
n1=Ostéosarcome | n2=en:malignant peripheral nerve sheath tumor with perineurial differentiation | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant peripheral nerve sheath tumors (21%)
n1=Ostéosarcome | n2=en:malignant peripheral nerve sheath tumors (21%) | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant pharyngeal neoplasm
n1=Ostéosarcome | n2=en:malignant pharyngeal neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant phyllodes tumor
n1=Ostéosarcome | n2=en:malignant phyllodes tumor | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant salivary gland neoplasm
n1=Ostéosarcome | n2=en:malignant salivary gland neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant sebaceous neoplasm
n1=Ostéosarcome | n2=en:malignant sebaceous neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant sertoli cell tumor
n1=Ostéosarcome | n2=en:malignant sertoli cell tumor | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant sex cord-stromal tumor
n1=Ostéosarcome | n2=en:malignant sex cord-stromal tumor | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant skin neoplasm
n1=Ostéosarcome | n2=en:malignant skin neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant solitary fibrous tumor
n1=Ostéosarcome | n2=en:malignant solitary fibrous tumor | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant spindle cell neoplasm
n1=Ostéosarcome | n2=en:malignant spindle cell neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant squamous cell neoplasm
n1=Ostéosarcome | n2=en:malignant squamous cell neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant struma ovarii
n1=Ostéosarcome | n2=en:malignant struma ovarii | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant tenosynovial giant cell tumor
n1=Ostéosarcome | n2=en:malignant tenosynovial giant cell tumor | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant testicular neoplasm
n1=Ostéosarcome | n2=en:malignant testicular neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant thymoma
n1=Ostéosarcome | n2=en:malignant thymoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant thyroid gland neoplasm
n1=Ostéosarcome | n2=en:malignant thyroid gland neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant triton tumor
n1=Ostéosarcome | n2=en:malignant triton tumor | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant trophoblastic teratoma
n1=Ostéosarcome | n2=en:malignant trophoblastic teratoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant tumor of lymphoid hemopoietic and related tissue
n1=Ostéosarcome | n2=en:malignant tumor of lymphoid hemopoietic and related tissue | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant tumor, clear cell type
n1=Ostéosarcome | n2=en:malignant tumor, clear cell type | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant tumor, small cell type
n1=Ostéosarcome | n2=en:malignant tumor, small cell type | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant type a thymoma
n1=Ostéosarcome | n2=en:malignant type a thymoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant type ab thymoma
n1=Ostéosarcome | n2=en:malignant type ab thymoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant type b1 thymoma
n1=Ostéosarcome | n2=en:malignant type b1 thymoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant type b2 thymoma
n1=Ostéosarcome | n2=en:malignant type b2 thymoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:malignant uterine neoplasm
n1=Ostéosarcome | n2=en:malignant uterine neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:mammary ductal fibroadenoma
n1=Ostéosarcome | n2=en:mammary ductal fibroadenoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:mast cell malignancy
n1=Ostéosarcome | n2=en:mast cell malignancy | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:mast cell sarcoma
n1=Ostéosarcome | n2=en:mast cell sarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:medullary carcinoma with lymphoid stroma
n1=Ostéosarcome | n2=en:medullary carcinoma with lymphoid stroma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:medulloblastoma
n1=Ostéosarcome | n2=en:medulloblastoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:medulloepithelioma
n1=Ostéosarcome | n2=en:medulloepithelioma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:melanocytic neoplasm
n1=Ostéosarcome | n2=en:melanocytic neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:melanoma
n1=Ostéosarcome | n2=en:melanoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:melanoma arising from blue nevus
n1=Ostéosarcome | n2=en:melanoma arising from blue nevus | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:melanoma in junctional nevus
n1=Ostéosarcome | n2=en:melanoma in junctional nevus | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:meningeal melanomatosis
n1=Ostéosarcome | n2=en:meningeal melanomatosis | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:meningeal sarcomatosis
n1=Ostéosarcome | n2=en:meningeal sarcomatosis | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:meningioma
n1=Ostéosarcome | n2=en:meningioma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:mesenchymal chondrosarcoma
n1=Ostéosarcome | n2=en:mesenchymal chondrosarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:mesenchymal chondrosarcoma of bone
n1=Ostéosarcome | n2=en:mesenchymal chondrosarcoma of bone | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:mesonephric adenocarcinoma
n1=Ostéosarcome | n2=en:mesonephric adenocarcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:mesonephric neoplasm
n1=Ostéosarcome | n2=en:mesonephric neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:mesothelial neoplasm
n1=Ostéosarcome | n2=en:mesothelial neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:mesothelioma
n1=Ostéosarcome | n2=en:mesothelioma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:mesothelioma (malignant, clinical disorder) (disorder)
n1=Ostéosarcome | n2=en:mesothelioma (malignant, clinical disorder) (disorder) | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:mesothelioma, malignant, after asbestos exposure
n1=Ostéosarcome | n2=en:mesothelioma, malignant, after asbestos exposure | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:metabolic aspects
n1=Ostéosarcome | n2=en:metabolic aspects | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:metaplastic carcinoma
n1=Ostéosarcome | n2=en:metaplastic carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:metastases to muscle
n1=Ostéosarcome | n2=en:metastases to muscle | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:metastases to perineum
n1=Ostéosarcome | n2=en:metastases to perineum | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:metastasis to lymph node from adenocarcinoma
n1=Ostéosarcome | n2=en:metastasis to lymph node from adenocarcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:metastasis to lymph node from squamous cell carcinoma
n1=Ostéosarcome | n2=en:metastasis to lymph node from squamous cell carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:metastasizing ameloblastoma
n1=Ostéosarcome | n2=en:metastasizing ameloblastoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:metastatic alveolar soft part sarcoma
n1=Ostéosarcome | n2=en:metastatic alveolar soft part sarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:metastatic angiosarcoma
n1=Ostéosarcome | n2=en:metastatic angiosarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:metastatic chondrosarcoma
n1=Ostéosarcome | n2=en:metastatic chondrosarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:metastatic epithelioid sarcoma
n1=Ostéosarcome | n2=en:metastatic epithelioid sarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:metastatic ewing sarcoma
n1=Ostéosarcome | n2=en:metastatic ewing sarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:metastatic extraskeletal ewing sarcoma
n1=Ostéosarcome | n2=en:metastatic extraskeletal ewing sarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:metastatic extraskeletal osteosarcoma
n1=Ostéosarcome | n2=en:metastatic extraskeletal osteosarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:metastatic fibrosarcoma
n1=Ostéosarcome | n2=en:metastatic fibrosarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:metastatic leiomyosarcoma
n1=Ostéosarcome | n2=en:metastatic leiomyosarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:metastatic liposarcoma
n1=Ostéosarcome | n2=en:metastatic liposarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:metastatic malignant neoplasm in the bone
n1=Ostéosarcome | n2=en:metastatic malignant neoplasm in the bone | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:metastatic malignant neoplasm in the chest wall
n1=Ostéosarcome | n2=en:metastatic malignant neoplasm in the chest wall | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:metastatic malignant neoplasm in the neck
n1=Ostéosarcome | n2=en:metastatic malignant neoplasm in the neck | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:metastatic malignant neoplasm in the skin
n1=Ostéosarcome | n2=en:metastatic malignant neoplasm in the skin | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:metastatic malignant neoplasm in the spine
n1=Ostéosarcome | n2=en:metastatic malignant neoplasm in the spine | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:metastatic malignant peripheral nerve sheath tumor
n1=Ostéosarcome | n2=en:metastatic malignant peripheral nerve sheath tumor | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:metastatic neoplasm
n1=Ostéosarcome | n2=en:metastatic neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:metastatic osteosarcoma
n1=Ostéosarcome | n2=en:metastatic osteosarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:metastatic peripheral primitive neuroectodermal tumor of bone
n1=Ostéosarcome | n2=en:metastatic peripheral primitive neuroectodermal tumor of bone | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:metastatic qualifier
n1=Ostéosarcome | n2=en:metastatic qualifier | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:metastatic synovial sarcoma
n1=Ostéosarcome | n2=en:metastatic synovial sarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:metastatic undifferentiated pleomorphic sarcoma
n1=Ostéosarcome | n2=en:metastatic undifferentiated pleomorphic sarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:microbiological
n1=Ostéosarcome | n2=en:microbiological | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:microcystic adnexal carcinoma
n1=Ostéosarcome | n2=en:microcystic adnexal carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:micropapillary transitional cell carcinoma
n1=Ostéosarcome | n2=en:micropapillary transitional cell carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:minimal deviation malignant melanoma
n1=Ostéosarcome | n2=en:minimal deviation malignant melanoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:miscellaneous and site unspecified neoplasms benign
n1=Ostéosarcome | n2=en:miscellaneous and site unspecified neoplasms benign | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:miscellaneous and site unspecified neoplasms malignant and unspecified
n1=Ostéosarcome | n2=en:miscellaneous and site unspecified neoplasms malignant and unspecified | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:mixed acinar-ductal carcinoma
n1=Ostéosarcome | n2=en:mixed acinar-ductal carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:mixed epithelioid and spindle cell melanoma
n1=Ostéosarcome | n2=en:mixed epithelioid and spindle cell melanoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:mixed germ cell tumor
n1=Ostéosarcome | n2=en:mixed germ cell tumor | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:mixed glioma
n1=Ostéosarcome | n2=en:mixed glioma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:mixed liposarcoma
n1=Ostéosarcome | n2=en:mixed liposarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:mixed mesodermal (mullerian) tumor
n1=Ostéosarcome | n2=en:mixed mesodermal (mullerian) tumor | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:mixed osteosarcoma
n1=Ostéosarcome | n2=en:mixed osteosarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:mixed osteosarcoma localized
n1=Ostéosarcome | n2=en:mixed osteosarcoma localized | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:mixed tumor, mesodermal
n1=Ostéosarcome | n2=en:mixed tumor, mesodermal | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:mixed type rhabdomyosarcoma
n1=Ostéosarcome | n2=en:mixed type rhabdomyosarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:monomorphic cells, medium-sized, with round nuclei, multiple nucleoli, and moderate amount of cytoplasm
n1=Ostéosarcome | n2=en:monomorphic cells, medium-sized, with round nuclei, multiple nucleoli, and moderate amount of cytoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:mouse osteosarcoma
n1=Ostéosarcome | n2=en:mouse osteosarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:mucin-producing adenocarcinoma
n1=Ostéosarcome | n2=en:mucin-producing adenocarcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:mucoepidermoid carcinoma
n1=Ostéosarcome | n2=en:mucoepidermoid carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:mucoepidermoid tumor
n1=Ostéosarcome | n2=en:mucoepidermoid tumor | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:mucosal lentiginous melanoma
n1=Ostéosarcome | n2=en:mucosal lentiginous melanoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:mucosal neuromas
n1=Ostéosarcome | n2=en:mucosal neuromas | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:multilobular chondroma and osteoma
n1=Ostéosarcome | n2=en:multilobular chondroma and osteoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:multiple bilateral renal angiomyolipoma
n1=Ostéosarcome | n2=en:multiple bilateral renal angiomyolipoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:multiple giant cell granulomas (bones, joints, soft tissues)
n1=Ostéosarcome | n2=en:multiple giant cell granulomas (bones, joints, soft tissues) | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:multiple osteochondromas
n1=Ostéosarcome | n2=en:multiple osteochondromas | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:multiple schwannomas
n1=Ostéosarcome | n2=en:multiple schwannomas | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:multiple tumors
n1=Ostéosarcome | n2=en:multiple tumors | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:multiple tumors in 28% of patients
n1=Ostéosarcome | n2=en:multiple tumors in 28% of patients | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:multiple tumors in 74% of patients
n1=Ostéosarcome | n2=en:multiple tumors in 74% of patients | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:myelodysplastic syndrome
n1=Ostéosarcome | n2=en:myelodysplastic syndrome | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:myelodysplastic syndrome with isolated del(5q)
n1=Ostéosarcome | n2=en:myelodysplastic syndrome with isolated del(5q) | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:myelodysplastic syndrome, no icd-o subtype
n1=Ostéosarcome | n2=en:myelodysplastic syndrome, no icd-o subtype | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:myeloid sarcoma
n1=Ostéosarcome | n2=en:myeloid sarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:myeloliposarcoma
n1=Ostéosarcome | n2=en:myeloliposarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:myeloproliferative neoplasm
n1=Ostéosarcome | n2=en:myeloproliferative neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:myocardial rhabdomyoma
n1=Ostéosarcome | n2=en:myocardial rhabdomyoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:myomatous neoplasm
n1=Ostéosarcome | n2=en:myomatous neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:myosarcoma
n1=Ostéosarcome | n2=en:myosarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:myxofibrosarcoma
n1=Ostéosarcome | n2=en:myxofibrosarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:myxoid chondrosarcoma
n1=Ostéosarcome | n2=en:myxoid chondrosarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:myxoid leiomyosarcoma
n1=Ostéosarcome | n2=en:myxoid leiomyosarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:myxoid liposarcoma
n1=Ostéosarcome | n2=en:myxoid liposarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:myxoid subcutaneous tumors
n1=Ostéosarcome | n2=en:myxoid subcutaneous tumors | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:myxoma
n1=Ostéosarcome | n2=en:myxoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:myxomatous neoplasm
n1=Ostéosarcome | n2=en:myxomatous neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:myxosarcoma
n1=Ostéosarcome | n2=en:myxosarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:nasal cavity and paranasal sinus carcinoma
n1=Ostéosarcome | n2=en:nasal cavity and paranasal sinus carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:nasopharyngeal carcinoma
n1=Ostéosarcome | n2=en:nasopharyngeal carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:nci ctep sdc osteosarcoma sub-category terminology
n1=Ostéosarcome | n2=en:nci ctep sdc osteosarcoma sub-category terminology | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:nci ctep simplified disease classification terminology
n1=Ostéosarcome | n2=en:nci ctep simplified disease classification terminology | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:ncit neoplasm core terminology
n1=Ostéosarcome | n2=en:ncit neoplasm core terminology | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:neoplasm
n1=Ostéosarcome | n2=en:neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:neoplasm by morphology
n1=Ostéosarcome | n2=en:neoplasm by morphology | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:neoplasm by site
n1=Ostéosarcome | n2=en:neoplasm by site | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:neoplasm by special category
n1=Ostéosarcome | n2=en:neoplasm by special category | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:neoplasm of articular cartilage
n1=Ostéosarcome | n2=en:neoplasm of articular cartilage | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:neoplasm of cartilage of nose
n1=Ostéosarcome | n2=en:neoplasm of cartilage of nose | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:neoplasm of perivascular myoid type - category
n1=Ostéosarcome | n2=en:neoplasm of perivascular myoid type - category | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:neoplasm of uncertain behavior of endocrine glands and nervous system
n1=Ostéosarcome | n2=en:neoplasm of uncertain behavior of endocrine glands and nervous system | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:neoplasm of uncertain behavior of other and unspecified sites and tissues
n1=Ostéosarcome | n2=en:neoplasm of uncertain behavior of other and unspecified sites and tissues | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:neoplasm of uncertain behavior of other specified sites
n1=Ostéosarcome | n2=en:neoplasm of uncertain behavior of other specified sites | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:neoplasm of uncertain behavior of skeletal system
n1=Ostéosarcome | n2=en:neoplasm of uncertain behavior of skeletal system | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:neoplasm of uncertain behavior, site unspecified
n1=Ostéosarcome | n2=en:neoplasm of uncertain behavior, site unspecified | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:neoplasm of uncertain malignant potential
n1=Ostéosarcome | n2=en:neoplasm of uncertain malignant potential | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:neoplasm of unspecified nature of bone, soft tissue, and skin
n1=Ostéosarcome | n2=en:neoplasm of unspecified nature of bone, soft tissue, and skin | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:neoplasm of unspecified nature of endocrine glands and other parts of nervous system
n1=Ostéosarcome | n2=en:neoplasm of unspecified nature of endocrine glands and other parts of nervous system | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:neoplasm of unspecified nature of other genitourinary organs
n1=Ostéosarcome | n2=en:neoplasm of unspecified nature of other genitourinary organs | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:neoplasm of unspecified nature of other specified sites
n1=Ostéosarcome | n2=en:neoplasm of unspecified nature of other specified sites | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:neoplasm of unspecified nature of respiratory system
n1=Ostéosarcome | n2=en:neoplasm of unspecified nature of respiratory system | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:neoplasm related morbidities
n1=Ostéosarcome | n2=en:neoplasm related morbidities | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:neoplasm, uncertain whether benign or malignant
n1=Ostéosarcome | n2=en:neoplasm, uncertain whether benign or malignant | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:neoplasm/cancer invasiveness
n1=Ostéosarcome | n2=en:neoplasm/cancer invasiveness | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:neoplasms by histologic type
n1=Ostéosarcome | n2=en:neoplasms by histologic type | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:neoplasms of uncertain or unknown behaviour
n1=Ostéosarcome | n2=en:neoplasms of uncertain or unknown behaviour | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:neoplasms, bone tissue
n1=Ostéosarcome | n2=en:neoplasms, bone tissue | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:neoplasms, experimental
n1=Ostéosarcome | n2=en:neoplasms, experimental | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:neoplasms, hormone-dependent
n1=Ostéosarcome | n2=en:neoplasms, hormone-dependent | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:neoplasms, multiple primary
n1=Ostéosarcome | n2=en:neoplasms, multiple primary | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:neoplasms, post-traumatic
n1=Ostéosarcome | n2=en:neoplasms, post-traumatic | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:neoplasms, second primary
n1=Ostéosarcome | n2=en:neoplasms, second primary | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:neoplastic cell
n1=Ostéosarcome | n2=en:neoplastic cell | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:neoplastic connective and soft tissue cell
n1=Ostéosarcome | n2=en:neoplastic connective and soft tissue cell | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:neoplastic osteoblast
n1=Ostéosarcome | n2=en:neoplastic osteoblast | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:neoplastic processes
n1=Ostéosarcome | n2=en:neoplastic processes | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:nervous system neoplasms malignant and unspecified nec
n1=Ostéosarcome | n2=en:nervous system neoplasms malignant and unspecified nec | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:nervous system tumor morphology
n1=Ostéosarcome | n2=en:nervous system tumor morphology | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:neural tissue tumors
n1=Ostéosarcome | n2=en:neural tissue tumors | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:neuroblastoma
n1=Ostéosarcome | n2=en:neuroblastoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:neuroblastoma (less common)
n1=Ostéosarcome | n2=en:neuroblastoma (less common) | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:neuroblastoma, arises anywhere along the sympathetic chain (including intracranially)
n1=Ostéosarcome | n2=en:neuroblastoma, arises anywhere along the sympathetic chain (including intracranially) | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:neuroendocrine neoplasm
n1=Ostéosarcome | n2=en:neuroendocrine neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:neuroepithelioma
n1=Ostéosarcome | n2=en:neuroepithelioma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:neuroepitheliomatous neoplasm
n1=Ostéosarcome | n2=en:neuroepitheliomatous neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:neurofibroma
n1=Ostéosarcome | n2=en:neurofibroma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:neuron, neuroepithelial cell, and supporting cell of the nervous system
n1=Ostéosarcome | n2=en:neuron, neuroepithelial cell, and supporting cell of the nervous system | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:neuronal or mixed neuronal-glial neoplasm
n1=Ostéosarcome | n2=en:neuronal or mixed neuronal-glial neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:nevus and/or melanoma
n1=Ostéosarcome | n2=en:nevus and/or melanoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:no cancer despite harboring complete deletions of the tp53 gene
n1=Ostéosarcome | n2=en:no cancer despite harboring complete deletions of the tp53 gene | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:no progression to cancer
n1=Ostéosarcome | n2=en:no progression to cancer | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:nodular melanoma
n1=Ostéosarcome | n2=en:nodular melanoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:non-hodgkin lymphoma
n1=Ostéosarcome | n2=en:non-hodgkin lymphoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:non-keratinizing sinonasal squamous cell carcinoma
n1=Ostéosarcome | n2=en:non-keratinizing sinonasal squamous cell carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:non-small cell carcinoma
n1=Ostéosarcome | n2=en:non-small cell carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:non-small cell lung carcinoma
n1=Ostéosarcome | n2=en:non-small cell lung carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:nonmelanoma skin cancer (in some patients)
n1=Ostéosarcome | n2=en:nonmelanoma skin cancer (in some patients) | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:nonseminoma (embryonal carcinoma, teratoma, choriocarcinoma, endodermal sinus tumor)
n1=Ostéosarcome | n2=en:nonseminoma (embryonal carcinoma, teratoma, choriocarcinoma, endodermal sinus tumor) | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:nonseminomatous germ cell tumor
n1=Ostéosarcome | n2=en:nonseminomatous germ cell tumor | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:nursing therapy
n1=Ostéosarcome | n2=en:nursing therapy | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:nutritional management
n1=Ostéosarcome | n2=en:nutritional management | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:odontogenic neoplasm
n1=Ostéosarcome | n2=en:odontogenic neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:olfactory neurogenic tumor
n1=Ostéosarcome | n2=en:olfactory neurogenic tumor | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:oligodendroglioma
n1=Ostéosarcome | n2=en:oligodendroglioma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:oncocytic adenoma
n1=Ostéosarcome | n2=en:oncocytic adenoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:optic glioma (19%)
n1=Ostéosarcome | n2=en:optic glioma (19%) | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:optic nerve glioma
n1=Ostéosarcome | n2=en:optic nerve glioma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:oropharyngeal carcinoma
n1=Ostéosarcome | n2=en:oropharyngeal carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:oropharyngeal squamous cell carcinoma
n1=Ostéosarcome | n2=en:oropharyngeal squamous cell carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:oslam syndrome
n1=Ostéosarcome | n2=en:oslam syndrome | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:osseous and chondromatous neoplasms
n1=Ostéosarcome | n2=en:osseous and chondromatous neoplasms | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:osseous and/or chondromatous neoplasm
n1=Ostéosarcome | n2=en:osseous and/or chondromatous neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:ossifying fibroma
n1=Ostéosarcome | n2=en:ossifying fibroma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:osteoblast
n1=Ostéosarcome | n2=en:osteoblast | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:osteoblastic osteosarcoma
n1=Ostéosarcome | n2=en:osteoblastic osteosarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:osteoblastic osteosarcoma localized
n1=Ostéosarcome | n2=en:osteoblastic osteosarcoma localized | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:osteoblastoma
n1=Ostéosarcome | n2=en:osteoblastoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:osteochondroma
n1=Ostéosarcome | n2=en:osteochondroma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:osteochondromyxoma
n1=Ostéosarcome | n2=en:osteochondromyxoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:osteofibrous dysplasia
n1=Ostéosarcome | n2=en:osteofibrous dysplasia | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:osteogenic/bone tumor, nos
n1=Ostéosarcome | n2=en:osteogenic/bone tumor, nos | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:osteogenic/bone tumor, special type
n1=Ostéosarcome | n2=en:osteogenic/bone tumor, special type | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:osteogenic/miscellaneous bone tumors (all subtypes)
n1=Ostéosarcome | n2=en:osteogenic/miscellaneous bone tumors (all subtypes) | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:osteoid osteoma
n1=Ostéosarcome | n2=en:osteoid osteoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:osteoma
n1=Ostéosarcome | n2=en:osteoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:osteosarcoma
n1=Ostéosarcome | n2=en:osteosarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:osteosarcoma and meningioma especially
n1=Ostéosarcome | n2=en:osteosarcoma and meningioma especially | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:osteosarcoma in paget disease of the mouse skeletal system
n1=Ostéosarcome | n2=en:osteosarcoma in paget disease of the mouse skeletal system | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:osteosarcoma in paget's disease of bone
n1=Ostéosarcome | n2=en:osteosarcoma in paget's disease of bone | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:osteosarcoma of bone of upper limb
n1=Ostéosarcome | n2=en:osteosarcoma of bone of upper limb | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:osteosarcoma of the mouse larynx
n1=Ostéosarcome | n2=en:osteosarcoma of the mouse larynx | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:osteosarcoma of the mouse nervous system
n1=Ostéosarcome | n2=en:osteosarcoma of the mouse nervous system | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:osteosarcoma of the mouse prostate gland
n1=Ostéosarcome | n2=en:osteosarcoma of the mouse prostate gland | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:osteosarcoma of the mouse skeletal system
n1=Ostéosarcome | n2=en:osteosarcoma of the mouse skeletal system | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:osteosarcoma of the mouse skeletal system, nos
n1=Ostéosarcome | n2=en:osteosarcoma of the mouse skeletal system, nos | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:osteosarcoma stage unspecified
n1=Ostéosarcome | n2=en:osteosarcoma stage unspecified | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:osteosarcoma, retinoblastoma-related
n1=Ostéosarcome | n2=en:osteosarcoma, retinoblastoma-related | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:osteosarcoma/malignant fibrous histiocytoma of bone
n1=Ostéosarcome | n2=en:osteosarcoma/malignant fibrous histiocytoma of bone | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:ovarian carcinoma
n1=Ostéosarcome | n2=en:ovarian carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:ovarian cystadenoma
n1=Ostéosarcome | n2=en:ovarian cystadenoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:ovarian germ cell tumor
n1=Ostéosarcome | n2=en:ovarian germ cell tumor | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:ovarian neoplasm
n1=Ostéosarcome | n2=en:ovarian neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:ovarian sarcoma
n1=Ostéosarcome | n2=en:ovarian sarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:ovarian sex cord-stromal tumor
n1=Ostéosarcome | n2=en:ovarian sex cord-stromal tumor | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:overlapping malignant melanoma of skin
n1=Ostéosarcome | n2=en:overlapping malignant melanoma of skin | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:overlapping malignant neoplasm of gastrointestinal tract
n1=Ostéosarcome | n2=en:overlapping malignant neoplasm of gastrointestinal tract | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:overlapping malignant neoplasm of ill-defined site
n1=Ostéosarcome | n2=en:overlapping malignant neoplasm of ill-defined site | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:overlapping malignant neoplasm of lip, oral cavity and pharynx
n1=Ostéosarcome | n2=en:overlapping malignant neoplasm of lip, oral cavity and pharynx | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:oxyphilic adenocarcinoma
n1=Ostéosarcome | n2=en:oxyphilic adenocarcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:paget disease and intraductal carcinoma of the breast
n1=Ostéosarcome | n2=en:paget disease and intraductal carcinoma of the breast | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:paget's disease and infiltrating duct carcinoma of breast
n1=Ostéosarcome | n2=en:paget's disease and infiltrating duct carcinoma of breast | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:pancreatic acinar cell cystadenocarcinoma
n1=Ostéosarcome | n2=en:pancreatic acinar cell cystadenocarcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:pancreatic adenocarcinoma
n1=Ostéosarcome | n2=en:pancreatic adenocarcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:pancreatic carcinoma
n1=Ostéosarcome | n2=en:pancreatic carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:pancreatic squamous cell carcinoma
n1=Ostéosarcome | n2=en:pancreatic squamous cell carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:pancreatoblastoma
n1=Ostéosarcome | n2=en:pancreatoblastoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:papillary meningioma
n1=Ostéosarcome | n2=en:papillary meningioma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:papillary neoplasm
n1=Ostéosarcome | n2=en:papillary neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:papillary renal cell carcinoma
n1=Ostéosarcome | n2=en:papillary renal cell carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:papillary thyroid carcinoma (rare)
n1=Ostéosarcome | n2=en:papillary thyroid carcinoma (rare) | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:papillary transitional cell carcinoma
n1=Ostéosarcome | n2=en:papillary transitional cell carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:paraganglioma
n1=Ostéosarcome | n2=en:paraganglioma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:paraganglioma, catecholamine-secreting
n1=Ostéosarcome | n2=en:paraganglioma, catecholamine-secreting | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:paragangliomas, head and neck (31%)
n1=Ostéosarcome | n2=en:paragangliomas, head and neck (31%) | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:paragangliomas, head and neck (79%)
n1=Ostéosarcome | n2=en:paragangliomas, head and neck (79%) | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:paraneoplastic sps is associated with autoantibodies to amphiphysin (amph, 600418)
n1=Ostéosarcome | n2=en:paraneoplastic sps is associated with autoantibodies to amphiphysin (amph, 600418) | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:paraneoplastic sps is associated with breast cancer and other malignancies
n1=Ostéosarcome | n2=en:paraneoplastic sps is associated with breast cancer and other malignancies | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:paraneoplastic syndrome
n1=Ostéosarcome | n2=en:paraneoplastic syndrome | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:parasitology
n1=Ostéosarcome | n2=en:parasitology | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:parathyroid disease rare
n1=Ostéosarcome | n2=en:parathyroid disease rare | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:parathyroid gland adenoma
n1=Ostéosarcome | n2=en:parathyroid gland adenoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:parathyroid gland carcinoma
n1=Ostéosarcome | n2=en:parathyroid gland carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:parosteal osteosarcoma
n1=Ostéosarcome | n2=en:parosteal osteosarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:parosteal osteosarcoma of the mouse skeletal system
n1=Ostéosarcome | n2=en:parosteal osteosarcoma of the mouse skeletal system | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:parotid gland adenoma and adenocarcinoma
n1=Ostéosarcome | n2=en:parotid gland adenoma and adenocarcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:parotid gland monomorphic adenoma
n1=Ostéosarcome | n2=en:parotid gland monomorphic adenoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:parotid oncocytomas
n1=Ostéosarcome | n2=en:parotid oncocytomas | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:pathological aspects
n1=Ostéosarcome | n2=en:pathological aspects | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:pediatric adverse events terminology
n1=Ostéosarcome | n2=en:pediatric adverse events terminology | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:pediatric terminology
n1=Ostéosarcome | n2=en:pediatric terminology | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:penile carcinoma
n1=Ostéosarcome | n2=en:penile carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:periampullary carcinoma nos
n1=Ostéosarcome | n2=en:periampullary carcinoma nos | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:periosteal chondroma
n1=Ostéosarcome | n2=en:periosteal chondroma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:periosteal chondrosarcoma
n1=Ostéosarcome | n2=en:periosteal chondrosarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:periosteal fibrosarcoma
n1=Ostéosarcome | n2=en:periosteal fibrosarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:periosteal osteosarcoma
n1=Ostéosarcome | n2=en:periosteal osteosarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:periosteal osteosarcoma of the mouse skeletal system
n1=Ostéosarcome | n2=en:periosteal osteosarcoma of the mouse skeletal system | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:peripheral primitive neuroectodermal tumor
n1=Ostéosarcome | n2=en:peripheral primitive neuroectodermal tumor | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:peripheral primitive neuroectodermal tumor of bone
n1=Ostéosarcome | n2=en:peripheral primitive neuroectodermal tumor of bone | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:peripheral primitive neuroectodermal tumor of soft tissues
n1=Ostéosarcome | n2=en:peripheral primitive neuroectodermal tumor of soft tissues | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:peripheral primitive neuroectodermal tumor of the kidney
n1=Ostéosarcome | n2=en:peripheral primitive neuroectodermal tumor of the kidney | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:pharmacotherapeutic
n1=Ostéosarcome | n2=en:pharmacotherapeutic | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:pheochromocytoma, adrenal (53%)
n1=Ostéosarcome | n2=en:pheochromocytoma, adrenal (53%) | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:pheochromocytoma, extraadrenal (21%)
n1=Ostéosarcome | n2=en:pheochromocytoma, extraadrenal (21%) | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:pheochromocytomas, adrenal (28%)
n1=Ostéosarcome | n2=en:pheochromocytomas, adrenal (28%) | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:pheochromocytomas, extraadrenal (48%)
n1=Ostéosarcome | n2=en:pheochromocytomas, extraadrenal (48%) | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:phyllodes tumor
n1=Ostéosarcome | n2=en:phyllodes tumor | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:physiopathological
n1=Ostéosarcome | n2=en:physiopathological | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:pilocytic astrocytoma
n1=Ostéosarcome | n2=en:pilocytic astrocytoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:pilomatrical carcinoma
n1=Ostéosarcome | n2=en:pilomatrical carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:pinealoma (trilateral retinoblastoma)
n1=Ostéosarcome | n2=en:pinealoma (trilateral retinoblastoma) | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:pituitary gland adenoma
n1=Ostéosarcome | n2=en:pituitary gland adenoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:pituitary gland neoplasm
n1=Ostéosarcome | n2=en:pituitary gland neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:plasma cell myeloma
n1=Ostéosarcome | n2=en:plasma cell myeloma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:plasma cell myeloma/plasmacytoma
n1=Ostéosarcome | n2=en:plasma cell myeloma/plasmacytoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:plasma cell neoplasm
n1=Ostéosarcome | n2=en:plasma cell neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:pleomorphic liposarcoma
n1=Ostéosarcome | n2=en:pleomorphic liposarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:pleomorphic rhabdomyosarcoma
n1=Ostéosarcome | n2=en:pleomorphic rhabdomyosarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:pleuropulmonary blastoma
n1=Ostéosarcome | n2=en:pleuropulmonary blastoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:polycythemia vera
n1=Ostéosarcome | n2=en:polycythemia vera | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:polyembryoma
n1=Ostéosarcome | n2=en:polyembryoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:polygonal cell carcinoma
n1=Ostéosarcome | n2=en:polygonal cell carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:polymorphous low grade adenocarcinoma
n1=Ostéosarcome | n2=en:polymorphous low grade adenocarcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:poorly differentiated carcinoma
n1=Ostéosarcome | n2=en:poorly differentiated carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:poorly differentiated sarcoma
n1=Ostéosarcome | n2=en:poorly differentiated sarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:possible increased risk of germ-cell tumors
n1=Ostéosarcome | n2=en:possible increased risk of germ-cell tumors | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:possibly increased risk for other cancers
n1=Ostéosarcome | n2=en:possibly increased risk for other cancers | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:possibly increased risk of cancer
n1=Ostéosarcome | n2=en:possibly increased risk of cancer | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:precancerous condition
n1=Ostéosarcome | n2=en:precancerous condition | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:precursor b-lymphoblastic leukemia/lymphoblastic lymphoma
n1=Ostéosarcome | n2=en:precursor b-lymphoblastic leukemia/lymphoblastic lymphoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:predisposition to uv-induced malignancies
n1=Ostéosarcome | n2=en:predisposition to uv-induced malignancies | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:pregnancy complications, neoplastic
n1=Ostéosarcome | n2=en:pregnancy complications, neoplastic | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:premature aging, okamoto type
n1=Ostéosarcome | n2=en:premature aging, okamoto type | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:primary adrenocortical nodular hyperplasia
n1=Ostéosarcome | n2=en:primary adrenocortical nodular hyperplasia | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:primary central chondrosarcoma
n1=Ostéosarcome | n2=en:primary central chondrosarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:primary malignant adenomatous neoplasm
n1=Ostéosarcome | n2=en:primary malignant adenomatous neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:primary malignant liver neoplasm
n1=Ostéosarcome | n2=en:primary malignant liver neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:primary malignant neoplasm of articular cartilage
n1=Ostéosarcome | n2=en:primary malignant neoplasm of articular cartilage | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:primary malignant neoplasm of back
n1=Ostéosarcome | n2=en:primary malignant neoplasm of back | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:primary malignant neoplasm of bone
n1=Ostéosarcome | n2=en:primary malignant neoplasm of bone | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:primary malignant neoplasm of ear, nose and/or throat
n1=Ostéosarcome | n2=en:primary malignant neoplasm of ear, nose and/or throat | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:primary malignant neoplasm of endocrine gland
n1=Ostéosarcome | n2=en:primary malignant neoplasm of endocrine gland | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:primary malignant neoplasm of gastrointestinal tract
n1=Ostéosarcome | n2=en:primary malignant neoplasm of gastrointestinal tract | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:primary malignant neoplasm of head
n1=Ostéosarcome | n2=en:primary malignant neoplasm of head | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:primary malignant neoplasm of ill-defined site
n1=Ostéosarcome | n2=en:primary malignant neoplasm of ill-defined site | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:primary malignant neoplasm of independent multiple sites
n1=Ostéosarcome | n2=en:primary malignant neoplasm of independent multiple sites | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:primary malignant neoplasm of lower limb
n1=Ostéosarcome | n2=en:primary malignant neoplasm of lower limb | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:primary malignant neoplasm of muscle
n1=Ostéosarcome | n2=en:primary malignant neoplasm of muscle | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:primary malignant neoplasm of neck
n1=Ostéosarcome | n2=en:primary malignant neoplasm of neck | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:primary malignant neoplasm of nervous system
n1=Ostéosarcome | n2=en:primary malignant neoplasm of nervous system | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:primary malignant neoplasm of paraganglion
n1=Ostéosarcome | n2=en:primary malignant neoplasm of paraganglion | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:primary malignant neoplasm of respiratory tract
n1=Ostéosarcome | n2=en:primary malignant neoplasm of respiratory tract | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:primary malignant neoplasm of soft tissues
n1=Ostéosarcome | n2=en:primary malignant neoplasm of soft tissues | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:primary malignant neoplasm of sweat gland
n1=Ostéosarcome | n2=en:primary malignant neoplasm of sweat gland | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:primary malignant neoplasm of trunk
n1=Ostéosarcome | n2=en:primary malignant neoplasm of trunk | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:primary malignant neoplasm of unknown site
n1=Ostéosarcome | n2=en:primary malignant neoplasm of unknown site | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:primary malignant neoplasm of unspecified site (clinical)
n1=Ostéosarcome | n2=en:primary malignant neoplasm of unspecified site (clinical) | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:primary malignant neoplasm of upper limb (disorder)
n1=Ostéosarcome | n2=en:primary malignant neoplasm of upper limb (disorder) | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:primary myelofibrosis
n1=Ostéosarcome | n2=en:primary myelofibrosis | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:primary osteosarcoma of pelvis
n1=Ostéosarcome | n2=en:primary osteosarcoma of pelvis | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:primary peritoneal cavity cancer
n1=Ostéosarcome | n2=en:primary peritoneal cavity cancer | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:primary undifferentiated large cell carcinoma
n1=Ostéosarcome | n2=en:primary undifferentiated large cell carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:primitive neuroectodermal tumor
n1=Ostéosarcome | n2=en:primitive neuroectodermal tumor | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:prolactin-producing pituitary gland adenoma
n1=Ostéosarcome | n2=en:prolactin-producing pituitary gland adenoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:prolymphocytic lymphosarcoma
n1=Ostéosarcome | n2=en:prolymphocytic lymphosarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:propensity to tumor development
n1=Ostéosarcome | n2=en:propensity to tumor development | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:prostate carcinoma
n1=Ostéosarcome | n2=en:prostate carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:psammomatous melanotic schwannomas
n1=Ostéosarcome | n2=en:psammomatous melanotic schwannomas | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:pseudoglandular squamous cell carcinoma
n1=Ostéosarcome | n2=en:pseudoglandular squamous cell carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:psychology qualifier
n1=Ostéosarcome | n2=en:psychology qualifier | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:radiation-related neoplasm
n1=Ostéosarcome | n2=en:radiation-related neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:radiation-related sarcoma
n1=Ostéosarcome | n2=en:radiation-related sarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:radiotherapeutic
n1=Ostéosarcome | n2=en:radiotherapeutic | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:rare childhood malignant neoplasm
n1=Ostéosarcome | n2=en:rare childhood malignant neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:rarely malignant
n1=Ostéosarcome | n2=en:rarely malignant | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:reactive immunoproliferative disease
n1=Ostéosarcome | n2=en:reactive immunoproliferative disease | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:rectal carcinoma
n1=Ostéosarcome | n2=en:rectal carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:recurrent alveolar soft part sarcoma
n1=Ostéosarcome | n2=en:recurrent alveolar soft part sarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:recurrent chondrosarcoma
n1=Ostéosarcome | n2=en:recurrent chondrosarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:recurrent epithelioid sarcoma
n1=Ostéosarcome | n2=en:recurrent epithelioid sarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:recurrent ewing sarcoma
n1=Ostéosarcome | n2=en:recurrent ewing sarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:recurrent extraskeletal ewing sarcoma
n1=Ostéosarcome | n2=en:recurrent extraskeletal ewing sarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:recurrent extraskeletal osteosarcoma
n1=Ostéosarcome | n2=en:recurrent extraskeletal osteosarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:recurrent leiomyosarcoma
n1=Ostéosarcome | n2=en:recurrent leiomyosarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:recurrent liposarcoma
n1=Ostéosarcome | n2=en:recurrent liposarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:recurrent malignant mesothelioma
n1=Ostéosarcome | n2=en:recurrent malignant mesothelioma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:recurrent malignant peripheral nerve sheath tumor
n1=Ostéosarcome | n2=en:recurrent malignant peripheral nerve sheath tumor | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:recurrent osteosarcoma
n1=Ostéosarcome | n2=en:recurrent osteosarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:recurrent peripheral primitive neuroectodermal tumor of bone
n1=Ostéosarcome | n2=en:recurrent peripheral primitive neuroectodermal tumor of bone | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:recurrent rhabdomyosarcoma
n1=Ostéosarcome | n2=en:recurrent rhabdomyosarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:recurrent synovial sarcoma
n1=Ostéosarcome | n2=en:recurrent synovial sarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:recurrent undifferentiated pleomorphic sarcoma
n1=Ostéosarcome | n2=en:recurrent undifferentiated pleomorphic sarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:refractory anemia
n1=Ostéosarcome | n2=en:refractory anemia | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:refractory anemia with excess blasts
n1=Ostéosarcome | n2=en:refractory anemia with excess blasts | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:refractory anemia with excess blasts in transformation
n1=Ostéosarcome | n2=en:refractory anemia with excess blasts in transformation | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:refractory anemia with ring sideroblasts
n1=Ostéosarcome | n2=en:refractory anemia with ring sideroblasts | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:refractory cytopenia with multilineage dysplasia
n1=Ostéosarcome | n2=en:refractory cytopenia with multilineage dysplasia | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:refractory cytopenia with multilineage dysplasia and ring sideroblasts
n1=Ostéosarcome | n2=en:refractory cytopenia with multilineage dysplasia and ring sideroblasts | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:regressed germ cell tumor
n1=Ostéosarcome | n2=en:regressed germ cell tumor | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:regressing melanoma
n1=Ostéosarcome | n2=en:regressing melanoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:rehabilitation aspects
n1=Ostéosarcome | n2=en:rehabilitation aspects | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:renal and urinary tract neoplasms benign
n1=Ostéosarcome | n2=en:renal and urinary tract neoplasms benign | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:renal and urinary tract neoplasms malignant and unspecified
n1=Ostéosarcome | n2=en:renal and urinary tract neoplasms malignant and unspecified | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:renal cell carcinoma
n1=Ostéosarcome | n2=en:renal cell carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:renal cell carcinoma (less common)
n1=Ostéosarcome | n2=en:renal cell carcinoma (less common) | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:renal cell carcinoma, solitary papillary type 2 (about 20% of patients)
n1=Ostéosarcome | n2=en:renal cell carcinoma, solitary papillary type 2 (about 20% of patients) | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:renal cell carcinoma, usually clear cell type
n1=Ostéosarcome | n2=en:renal cell carcinoma, usually clear cell type | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:renal cortical adenoma
n1=Ostéosarcome | n2=en:renal cortical adenoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:renal pelvis and ureter urothelial carcinoma
n1=Ostéosarcome | n2=en:renal pelvis and ureter urothelial carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:reported colon and other abdominal cancer in relatives
n1=Ostéosarcome | n2=en:reported colon and other abdominal cancer in relatives | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:reproductive and genitourinary neoplasms gender unspecified nec
n1=Ostéosarcome | n2=en:reproductive and genitourinary neoplasms gender unspecified nec | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:reproductive neoplasms female malignant and unspecified
n1=Ostéosarcome | n2=en:reproductive neoplasms female malignant and unspecified | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:reproductive neoplasms male malignant and unspecified
n1=Ostéosarcome | n2=en:reproductive neoplasms male malignant and unspecified | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:respiratory and mediastinal neoplasms benign (excl mesotheliomas)
n1=Ostéosarcome | n2=en:respiratory and mediastinal neoplasms benign (excl mesotheliomas) | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:respiratory and mediastinal neoplasms malignant and unspecified
n1=Ostéosarcome | n2=en:respiratory and mediastinal neoplasms malignant and unspecified | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:retinoblastoma
n1=Ostéosarcome | n2=en:retinoblastoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:retroperitoneal sarcoma
n1=Ostéosarcome | n2=en:retroperitoneal sarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:rhabdoid tumor
n1=Ostéosarcome | n2=en:rhabdoid tumor | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:rhabdoid tumor of the kidney
n1=Ostéosarcome | n2=en:rhabdoid tumor of the kidney | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:rhabdoid tumors, malignant (renal or extrarenal)
n1=Ostéosarcome | n2=en:rhabdoid tumors, malignant (renal or extrarenal) | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:rhabdomyosarcoma
n1=Ostéosarcome | n2=en:rhabdomyosarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:roentgenographic
n1=Ostéosarcome | n2=en:roentgenographic | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:rothmund-thomson syndrome
n1=Ostéosarcome | n2=en:rothmund-thomson syndrome | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:round cell liposarcoma
n1=Ostéosarcome | n2=en:round cell liposarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:sacrococcygeal teratoma
n1=Ostéosarcome | n2=en:sacrococcygeal teratoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:sarcoma
n1=Ostéosarcome | n2=en:sarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:sarcoma by ajcc grade
n1=Ostéosarcome | n2=en:sarcoma by ajcc grade | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:sarcoma by fnclcc grade
n1=Ostéosarcome | n2=en:sarcoma by fnclcc grade | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:sarcoma by nci grade
n1=Ostéosarcome | n2=en:sarcoma by nci grade | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:sarcoma of back
n1=Ostéosarcome | n2=en:sarcoma of back | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:sarcoma of bone and connective tissue
n1=Ostéosarcome | n2=en:sarcoma of bone and connective tissue | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:sarcoma of bone of foot
n1=Ostéosarcome | n2=en:sarcoma of bone of foot | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:sarcoma of bone of pelvis
n1=Ostéosarcome | n2=en:sarcoma of bone of pelvis | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:sarcoma of clavicle
n1=Ostéosarcome | n2=en:sarcoma of clavicle | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:sarcoma of femur
n1=Ostéosarcome | n2=en:sarcoma of femur | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:sarcoma of fibula
n1=Ostéosarcome | n2=en:sarcoma of fibula | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:sarcoma of head and neck
n1=Ostéosarcome | n2=en:sarcoma of head and neck | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:sarcoma of humerus
n1=Ostéosarcome | n2=en:sarcoma of humerus | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:sarcoma of mandible
n1=Ostéosarcome | n2=en:sarcoma of mandible | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:sarcoma of pelvis
n1=Ostéosarcome | n2=en:sarcoma of pelvis | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:sarcoma of posterior mediastinum
n1=Ostéosarcome | n2=en:sarcoma of posterior mediastinum | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:sarcoma of radius
n1=Ostéosarcome | n2=en:sarcoma of radius | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:sarcoma of rib
n1=Ostéosarcome | n2=en:sarcoma of rib | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:sarcoma of sacrum
n1=Ostéosarcome | n2=en:sarcoma of sacrum | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:sarcoma of scapula
n1=Ostéosarcome | n2=en:sarcoma of scapula | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:sarcoma of skull
n1=Ostéosarcome | n2=en:sarcoma of skull | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:sarcoma of sternum
n1=Ostéosarcome | n2=en:sarcoma of sternum | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:sarcoma of tibia
n1=Ostéosarcome | n2=en:sarcoma of tibia | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:sarcoma of vertebra
n1=Ostéosarcome | n2=en:sarcoma of vertebra | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:sarcoma, experimental
n1=Ostéosarcome | n2=en:sarcoma, experimental | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:sarcoma, metastatic
n1=Ostéosarcome | n2=en:sarcoma, metastatic | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:sarcomatoid carcinoma
n1=Ostéosarcome | n2=en:sarcomatoid carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:sarcomatoid mesothelioma
n1=Ostéosarcome | n2=en:sarcomatoid mesothelioma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:sarcomatoid squamous cell carcinoma
n1=Ostéosarcome | n2=en:sarcomatoid squamous cell carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:sarcomatoid transitional cell carcinoma
n1=Ostéosarcome | n2=en:sarcomatoid transitional cell carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:sarcomatosis
n1=Ostéosarcome | n2=en:sarcomatosis | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:schwannoma
n1=Ostéosarcome | n2=en:schwannoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:sebaceous adenoma
n1=Ostéosarcome | n2=en:sebaceous adenoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:sebaceous carcinoma
n1=Ostéosarcome | n2=en:sebaceous carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:sebaceous epithelioma
n1=Ostéosarcome | n2=en:sebaceous epithelioma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:second primary malignant neoplasm
n1=Ostéosarcome | n2=en:second primary malignant neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:secondary chondrosarcoma
n1=Ostéosarcome | n2=en:secondary chondrosarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:secondary malignant neoplasm of soft tissues
n1=Ostéosarcome | n2=en:secondary malignant neoplasm of soft tissues | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:secondary osteosarcoma
n1=Ostéosarcome | n2=en:secondary osteosarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:secretory breast carcinoma
n1=Ostéosarcome | n2=en:secretory breast carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:seminoma
n1=Ostéosarcome | n2=en:seminoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:sensitivity to genotoxic agents
n1=Ostéosarcome | n2=en:sensitivity to genotoxic agents | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:seromucinous carcinoma
n1=Ostéosarcome | n2=en:seromucinous carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:sertoli cell carcinoma
n1=Ostéosarcome | n2=en:sertoli cell carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:sertoli cell tumor
n1=Ostéosarcome | n2=en:sertoli cell tumor | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:sertoli-leydig cell ovarian tumors may occur
n1=Ostéosarcome | n2=en:sertoli-leydig cell ovarian tumors may occur | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:sertoli-leydig cell tumor, poorly differentiated
n1=Ostéosarcome | n2=en:sertoli-leydig cell tumor, poorly differentiated | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:sertoli-leydig cell tumor, poorly differentiated, with heterologous elements
n1=Ostéosarcome | n2=en:sertoli-leydig cell tumor, poorly differentiated, with heterologous elements | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:sex cord-stromal tumor
n1=Ostéosarcome | n2=en:sex cord-stromal tumor | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:signet ring cell carcinoma
n1=Ostéosarcome | n2=en:signet ring cell carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:sinonasal undifferentiated carcinoma
n1=Ostéosarcome | n2=en:sinonasal undifferentiated carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:skeletal neoplasm
n1=Ostéosarcome | n2=en:skeletal neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:skeletal neoplasms benign
n1=Ostéosarcome | n2=en:skeletal neoplasms benign | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:skeletal neoplasms malignant and unspecified
n1=Ostéosarcome | n2=en:skeletal neoplasms malignant and unspecified | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:skin adenoid basal cell carcinoma
n1=Ostéosarcome | n2=en:skin adenoid basal cell carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:skin appendage tumors may show malignant transformation
n1=Ostéosarcome | n2=en:skin appendage tumors may show malignant transformation | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:skin basal cell carcinoma
n1=Ostéosarcome | n2=en:skin basal cell carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:skin basosquamous cell carcinoma
n1=Ostéosarcome | n2=en:skin basosquamous cell carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:skin cancer susceptibility
n1=Ostéosarcome | n2=en:skin cancer susceptibility | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:skin carcinoma
n1=Ostéosarcome | n2=en:skin carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:skin fibroepithelial basal cell carcinoma
n1=Ostéosarcome | n2=en:skin fibroepithelial basal cell carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:skin infiltrating basal cell carcinoma
n1=Ostéosarcome | n2=en:skin infiltrating basal cell carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:skin metatypical carcinoma
n1=Ostéosarcome | n2=en:skin metatypical carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:skin nodular basal cell carcinoma
n1=Ostéosarcome | n2=en:skin nodular basal cell carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:skin sarcoma
n1=Ostéosarcome | n2=en:skin sarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:skin squamous cell carcinoma
n1=Ostéosarcome | n2=en:skin squamous cell carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:small cell carcinoma
n1=Ostéosarcome | n2=en:small cell carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:small cell carcinoma carcinomatosis
n1=Ostéosarcome | n2=en:small cell carcinoma carcinomatosis | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:small cell carcinoma of the ovary, hypercalcemic type
n1=Ostéosarcome | n2=en:small cell carcinoma of the ovary, hypercalcemic type | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:small cell carcinoma, fusiform cell type
n1=Ostéosarcome | n2=en:small cell carcinoma, fusiform cell type | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:small cell intermediate cell carcinoma
n1=Ostéosarcome | n2=en:small cell intermediate cell carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:small cell lung carcinoma
n1=Ostéosarcome | n2=en:small cell lung carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:small cell osteosarcoma
n1=Ostéosarcome | n2=en:small cell osteosarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:small cell osteosarcoma of the mouse skeletal system
n1=Ostéosarcome | n2=en:small cell osteosarcoma of the mouse skeletal system | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:small cell sarcoma
n1=Ostéosarcome | n2=en:small cell sarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:small intestinal carcinoma
n1=Ostéosarcome | n2=en:small intestinal carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:small intestine carcinoid
n1=Ostéosarcome | n2=en:small intestine carcinoid | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:soft tissue neoplasms malignant and unspecified
n1=Ostéosarcome | n2=en:soft tissue neoplasms malignant and unspecified | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:soft tissue sarcoma
n1=Ostéosarcome | n2=en:soft tissue sarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:soft tissue tumor and/or sarcoma
n1=Ostéosarcome | n2=en:soft tissue tumor and/or sarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:solid neoplasm
n1=Ostéosarcome | n2=en:solid neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:solid papillary carcinoma with invasion
n1=Ostéosarcome | n2=en:solid papillary carcinoma with invasion | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:solid pseudopapillary carcinoma
n1=Ostéosarcome | n2=en:solid pseudopapillary carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:somatostatin-producing neuroendocrine tumor
n1=Ostéosarcome | n2=en:somatostatin-producing neuroendocrine tumor | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:spindle cell melanoma
n1=Ostéosarcome | n2=en:spindle cell melanoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:spindle cell rhabdomyosarcoma
n1=Ostéosarcome | n2=en:spindle cell rhabdomyosarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:spindle cell sarcoma
n1=Ostéosarcome | n2=en:spindle cell sarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:spiradenocarcinoma
n1=Ostéosarcome | n2=en:spiradenocarcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:spongioneuroblastoma
n1=Ostéosarcome | n2=en:spongioneuroblastoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:squamous cell carcinoma
n1=Ostéosarcome | n2=en:squamous cell carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:squamous cell carcinoma (1 patient)
n1=Ostéosarcome | n2=en:squamous cell carcinoma (1 patient) | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:squamous cell carcinoma (skin and tongue)
n1=Ostéosarcome | n2=en:squamous cell carcinoma (skin and tongue) | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:squamous cell carcinoma (skin or mucosa)
n1=Ostéosarcome | n2=en:squamous cell carcinoma (skin or mucosa) | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:squamous cell carcinoma in area of palmoplantar keratoderma (rare)
n1=Ostéosarcome | n2=en:squamous cell carcinoma in area of palmoplantar keratoderma (rare) | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:squamous cell carcinoma metastatic in the neck with occult primary
n1=Ostéosarcome | n2=en:squamous cell carcinoma metastatic in the neck with occult primary | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:squamous epitheliomas, multiple
n1=Ostéosarcome | n2=en:squamous epitheliomas, multiple | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:stage i bone sarcoma
n1=Ostéosarcome | n2=en:stage i bone sarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:stage ii bone sarcoma
n1=Ostéosarcome | n2=en:stage ii bone sarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:stage iii bone sarcoma
n1=Ostéosarcome | n2=en:stage iii bone sarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:stage iv bone sarcoma
n1=Ostéosarcome | n2=en:stage iv bone sarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:stage, osteosarcoma
n1=Ostéosarcome | n2=en:stage, osteosarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:starry sky pattern
n1=Ostéosarcome | n2=en:starry sky pattern | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:statistical association of extensive metabolism (em, wildtype) and malignancy, especially smoking-induced lung cancer
n1=Ostéosarcome | n2=en:statistical association of extensive metabolism (em, wildtype) and malignancy, especially smoking-induced lung cancer | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:steroid cell tumor, malignant
n1=Ostéosarcome | n2=en:steroid cell tumor, malignant | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:storiform-pleomorphic malignant fibrous histiocytoma
n1=Ostéosarcome | n2=en:storiform-pleomorphic malignant fibrous histiocytoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:stromal sarcoma
n1=Ostéosarcome | n2=en:stromal sarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:subependymoma
n1=Ostéosarcome | n2=en:subependymoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:subungual exostosis
n1=Ostéosarcome | n2=en:subungual exostosis | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:superficial multifocal basal cell carcinoma
n1=Ostéosarcome | n2=en:superficial multifocal basal cell carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:superficial spreading melanoma
n1=Ostéosarcome | n2=en:superficial spreading melanoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:surgical aspects
n1=Ostéosarcome | n2=en:surgical aspects | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:susceptibility to malignant melanoma
n1=Ostéosarcome | n2=en:susceptibility to malignant melanoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:susceptibility to myelodysplasia
n1=Ostéosarcome | n2=en:susceptibility to myelodysplasia | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:susceptibility to myeloid leukemia
n1=Ostéosarcome | n2=en:susceptibility to myeloid leukemia | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:sweat gland adenocarcinoma
n1=Ostéosarcome | n2=en:sweat gland adenocarcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:synovial neoplasm
n1=Ostéosarcome | n2=en:synovial neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:synovial sarcoma
n1=Ostéosarcome | n2=en:synovial sarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:synovial sarcoma - category
n1=Ostéosarcome | n2=en:synovial sarcoma - category | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:synovial-like neoplasm
n1=Ostéosarcome | n2=en:synovial-like neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:syringocystadenoma papilliferum
n1=Ostéosarcome | n2=en:syringocystadenoma papilliferum | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:t lymphoblastic leukemia/lymphoma
n1=Ostéosarcome | n2=en:t lymphoblastic leukemia/lymphoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:t-cell non-hodgkin lymphoma
n1=Ostéosarcome | n2=en:t-cell non-hodgkin lymphoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:taxonomic
n1=Ostéosarcome | n2=en:taxonomic | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:telangiectatic osteosarcoma
n1=Ostéosarcome | n2=en:telangiectatic osteosarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:telangiectatic osteosarcoma localized
n1=Ostéosarcome | n2=en:telangiectatic osteosarcoma localized | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:telangiectatic osteosarcoma of the mouse skeletal system
n1=Ostéosarcome | n2=en:telangiectatic osteosarcoma of the mouse skeletal system | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:teratoid medulloepithelioma
n1=Ostéosarcome | n2=en:teratoid medulloepithelioma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:teratoid tumor, atypical
n1=Ostéosarcome | n2=en:teratoid tumor, atypical | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:testicular sertoli cell tumor
n1=Ostéosarcome | n2=en:testicular sertoli cell tumor | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:testicular sertoli cell tumor, calcified
n1=Ostéosarcome | n2=en:testicular sertoli cell tumor, calcified | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:testicular spermatocytic seminoma
n1=Ostéosarcome | n2=en:testicular spermatocytic seminoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:therapeutic aspects
n1=Ostéosarcome | n2=en:therapeutic aspects | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:therapy-related myelodysplastic syndrome
n1=Ostéosarcome | n2=en:therapy-related myelodysplastic syndrome | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:thymic carcinoma
n1=Ostéosarcome | n2=en:thymic carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:thymoma
n1=Ostéosarcome | n2=en:thymoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:thymoma type b3
n1=Ostéosarcome | n2=en:thymoma type b3 | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:thyroid cancer (follicular cell)
n1=Ostéosarcome | n2=en:thyroid cancer (follicular cell) | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:thyroid follicular cell tumor
n1=Ostéosarcome | n2=en:thyroid follicular cell tumor | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:thyroid gland carcinoma
n1=Ostéosarcome | n2=en:thyroid gland carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:thyroid gland carcinoma showing thymus-like differentiation
n1=Ostéosarcome | n2=en:thyroid gland carcinoma showing thymus-like differentiation | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:thyroid gland diffuse sclerosing papillary carcinoma
n1=Ostéosarcome | n2=en:thyroid gland diffuse sclerosing papillary carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:thyroid gland medullary carcinoma
n1=Ostéosarcome | n2=en:thyroid gland medullary carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:thyroid gland oncocytic adenoma
n1=Ostéosarcome | n2=en:thyroid gland oncocytic adenoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:thyroid gland oncocytic neoplasm
n1=Ostéosarcome | n2=en:thyroid gland oncocytic neoplasm | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:thyroid gland papillary carcinoma
n1=Ostéosarcome | n2=en:thyroid gland papillary carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:thyroid gland spindle cell tumor with thymus-like differentiation
n1=Ostéosarcome | n2=en:thyroid gland spindle cell tumor with thymus-like differentiation | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:tp53 gene
n1=Ostéosarcome | n2=en:tp53 gene | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:tp53 wt allele
n1=Ostéosarcome | n2=en:tp53 wt allele | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:tp53, 7-bp ins, nt13160
n1=Ostéosarcome | n2=en:tp53, 7-bp ins, nt13160 | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:tp53*1 allele
n1=Ostéosarcome | n2=en:tp53*1 allele | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:transitional cell carcinoma
n1=Ostéosarcome | n2=en:transitional cell carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:trichilemmocarcinoma
n1=Ostéosarcome | n2=en:trichilemmocarcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:trichoblastoma
n1=Ostéosarcome | n2=en:trichoblastoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:trichoepitheliomas may rarely show malignant transformation to basal cell carcinoma
n1=Ostéosarcome | n2=en:trichoepitheliomas may rarely show malignant transformation to basal cell carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:trophoblastic tumor
n1=Ostéosarcome | n2=en:trophoblastic tumor | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:tumor cells, benign
n1=Ostéosarcome | n2=en:tumor cells, benign | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:tumor in vein
n1=Ostéosarcome | n2=en:tumor in vein | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:tumors at multiple other sites including cns
n1=Ostéosarcome | n2=en:tumors at multiple other sites including cns | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:tumors of the sympathetic nervous system (5 to 10%)
n1=Ostéosarcome | n2=en:tumors of the sympathetic nervous system (5 to 10%) | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:type a spindle cell melanoma
n1=Ostéosarcome | n2=en:type a spindle cell melanoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:type b spindle cell melanoma
n1=Ostéosarcome | n2=en:type b spindle cell melanoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:ultrastructure
n1=Ostéosarcome | n2=en:ultrastructure | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:undifferentiated (embryonal) sarcoma
n1=Ostéosarcome | n2=en:undifferentiated (embryonal) sarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:undifferentiated carcinoma
n1=Ostéosarcome | n2=en:undifferentiated carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:undifferentiated high grade pleomorphic sarcoma of bone
n1=Ostéosarcome | n2=en:undifferentiated high grade pleomorphic sarcoma of bone | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:undifferentiated pleomorphic sarcoma
n1=Ostéosarcome | n2=en:undifferentiated pleomorphic sarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:undifferentiated pleomorphic sarcoma with osteoclast-like giant cells
n1=Ostéosarcome | n2=en:undifferentiated pleomorphic sarcoma with osteoclast-like giant cells | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:undifferentiated pleomorphic sarcoma, inflammatory variant
n1=Ostéosarcome | n2=en:undifferentiated pleomorphic sarcoma, inflammatory variant | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:undifferentiated sarcoma, not otherwise specified
n1=Ostéosarcome | n2=en:undifferentiated sarcoma, not otherwise specified | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:unilateral vestibular schwannoma
n1=Ostéosarcome | n2=en:unilateral vestibular schwannoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:unspecified adult solid tumor, protocol specific
n1=Ostéosarcome | n2=en:unspecified adult solid tumor, protocol specific | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:unspecified childhood solid tumor, protocol specific
n1=Ostéosarcome | n2=en:unspecified childhood solid tumor, protocol specific | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:unusual cancers of childhood
n1=Ostéosarcome | n2=en:unusual cancers of childhood | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:urethral carcinoma
n1=Ostéosarcome | n2=en:urethral carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:use of ultrasonography
n1=Ostéosarcome | n2=en:use of ultrasonography | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:uterine corpus sarcoma
n1=Ostéosarcome | n2=en:uterine corpus sarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:uterine leiomyosarcoma (less common)
n1=Ostéosarcome | n2=en:uterine leiomyosarcoma (less common) | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:uveal melanoma
n1=Ostéosarcome | n2=en:uveal melanoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:vaccine-induced fibrosarcoma
n1=Ostéosarcome | n2=en:vaccine-induced fibrosarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:vaginal carcinoma
n1=Ostéosarcome | n2=en:vaginal carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:vagus nerve paraganglioma
n1=Ostéosarcome | n2=en:vagus nerve paraganglioma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:verrucous carcinoma
n1=Ostéosarcome | n2=en:verrucous carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:vestibular schwannoma (over 90% of patients)
n1=Ostéosarcome | n2=en:vestibular schwannoma (over 90% of patients) | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:veterinary aspects
n1=Ostéosarcome | n2=en:veterinary aspects | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:viruses
n1=Ostéosarcome | n2=en:viruses | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:vulvar carcinoma
n1=Ostéosarcome | n2=en:vulvar carcinoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:vulvar sarcoma
n1=Ostéosarcome | n2=en:vulvar sarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:well differentiated liposarcoma
n1=Ostéosarcome | n2=en:well differentiated liposarcoma | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:werner syndrome
n1=Ostéosarcome | n2=en:werner syndrome | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
en:wilms tumor and other childhood kidney tumors
n1=Ostéosarcome | n2=en:wilms tumor and other childhood kidney tumors | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
épendymome
n1=Ostéosarcome | n2=épendymome | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
glioblastome
n1=Ostéosarcome | n2=glioblastome | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
gliome
n1=Ostéosarcome | n2=gliome | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
grosseur
n1=Ostéosarcome | n2=grosseur | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
hémangioblastome
n1=Ostéosarcome | n2=hémangioblastome | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
image en feux d'herbe
n1=Ostéosarcome | n2=image en feux d'herbe | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
imagerie par résonance magnétique
n1=Ostéosarcome | n2=imagerie par résonance magnétique | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
IRM
n1=Ostéosarcome | n2=IRM | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
lésion
n1=Ostéosarcome | n2=lésion | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
malade
n1=Ostéosarcome | n2=malade | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
maladie
n1=Ostéosarcome | n2=maladie | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
maladie neurologique
n1=Ostéosarcome | n2=maladie neurologique | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
maladie
(médecine)
n1=Ostéosarcome | n2=maladie (médecine) | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
maladie
(médecine, vétérinaire)
n1=Ostéosarcome | n2=maladie (médecine, vétérinaire) | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
Médecine
n1=Ostéosarcome | n2=Médecine | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
médecine
(science)
n1=Ostéosarcome | n2=médecine (science) | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
médulloblastome
n1=Ostéosarcome | n2=médulloblastome | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
méningiome
n1=Ostéosarcome | n2=méningiome | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
mort
n1=Ostéosarcome | n2=mort | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
néoplasie
n1=Ostéosarcome | n2=néoplasie | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
neurochirurgie
n1=Ostéosarcome | n2=neurochirurgie | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
neurocytome
n1=Ostéosarcome | n2=neurocytome | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
neurologie
n1=Ostéosarcome | n2=neurologie | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
oligodendrogliome
n1=Ostéosarcome | n2=oligodendrogliome | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
os et articulations
n1=Ostéosarcome | n2=os et articulations | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
ostéide
n1=Ostéosarcome | n2=ostéide | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
ostéochondrosarcome
n1=Ostéosarcome | n2=ostéochondrosarcome | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
ostéoïde
n1=Ostéosarcome | n2=ostéoïde | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
ostéolytique
n1=Ostéosarcome | n2=ostéolytique | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
ostéoporose-pseudogliome (syndrome)
n1=Ostéosarcome | n2=ostéoporose-pseudogliome (syndrome) | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
ostéosarcome à petites cellules
n1=Ostéosarcome | n2=ostéosarcome à petites cellules | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
ostéosarcome juxtacortical
n1=Ostéosarcome | n2=ostéosarcome juxtacortical | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
ostéosarcome ostéogénique
n1=Ostéosarcome | n2=ostéosarcome ostéogénique | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
ostéosarcome périosté
n1=Ostéosarcome | n2=ostéosarcome périosté | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
ostéosarcome télangiectasique
n1=Ostéosarcome | n2=ostéosarcome télangiectasique | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
ostéosarcomes
n1=Ostéosarcome | n2=ostéosarcomes | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
papillome du plexus choroïde
n1=Ostéosarcome | n2=papillome du plexus choroïde | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
pathologie du système ostéo-articulaire
n1=Ostéosarcome | n2=pathologie du système ostéo-articulaire | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
pathologie du système ostéoarticulaire
n1=Ostéosarcome | n2=pathologie du système ostéoarticulaire | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
pathologie ostéo-articulaire
n1=Ostéosarcome | n2=pathologie ostéo-articulaire | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
pathologie
(maladie)
n1=Ostéosarcome | n2=pathologie (maladie) | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
pinéalome
n1=Ostéosarcome | n2=pinéalome | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
processus pathologique
n1=Ostéosarcome | n2=processus pathologique | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
prolifération
n1=Ostéosarcome | n2=prolifération | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
réaction périostée
n1=Ostéosarcome | n2=réaction périostée | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
sarcome
n1=Ostéosarcome | n2=sarcome | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
sarcome osseux
n1=Ostéosarcome | n2=sarcome osseux | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
sarcome ostéoblastique
n1=Ostéosarcome | n2=sarcome ostéoblastique | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
sarcome ostéogène
n1=Ostéosarcome | n2=sarcome ostéogène | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
sarcome ostéogénique
n1=Ostéosarcome | n2=sarcome ostéogénique | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
sarcome ostéogénique (? éviter )
n1=Ostéosarcome | n2=sarcome ostéogénique (? éviter ) | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
sarcome squelettogène
n1=Ostéosarcome | n2=sarcome squelettogène | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
sarcomes osseux
n1=Ostéosarcome | n2=sarcomes osseux | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
scanner
n1=Ostéosarcome | n2=scanner | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
scanner
(médecine)
n1=Ostéosarcome | n2=scanner (médecine) | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
schwannome
n1=Ostéosarcome | n2=schwannome | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
spicule
n1=Ostéosarcome | n2=spicule | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
syndrome de Li-Fraumeni
n1=Ostéosarcome | n2=syndrome de Li-Fraumeni | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
triangle de Codman
n1=Ostéosarcome | n2=triangle de Codman | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
tumeur
n1=Ostéosarcome | n2=tumeur | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
tumeur bénigne
n1=Ostéosarcome | n2=tumeur bénigne | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
tumeur bénigne de la moelle épinière
n1=Ostéosarcome | n2=tumeur bénigne de la moelle épinière | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
tumeur bénigne du cerveau
n1=Ostéosarcome | n2=tumeur bénigne du cerveau | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
tumeur bénigne du système nerveux central
n1=Ostéosarcome | n2=tumeur bénigne du système nerveux central | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
tumeur cérébrale bénigne
n1=Ostéosarcome | n2=tumeur cérébrale bénigne | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
tumeur cérébrale maligne
n1=Ostéosarcome | n2=tumeur cérébrale maligne | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
tumeur des méninges
n1=Ostéosarcome | n2=tumeur des méninges | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
tumeur du système nerveux central
n1=Ostéosarcome | n2=tumeur du système nerveux central | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
tumeur du tissu conjonctif
n1=Ostéosarcome | n2=tumeur du tissu conjonctif | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
tumeur du tissu osseux
n1=Ostéosarcome | n2=tumeur du tissu osseux | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
tumeur extra-axiale
n1=Ostéosarcome | n2=tumeur extra-axiale | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
tumeur maligne
n1=Ostéosarcome | n2=tumeur maligne | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
tumeur maligne du système nerveux central
n1=Ostéosarcome | n2=tumeur maligne du système nerveux central | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 15 / 0.188 ->
tumeur osseuse
n1=Ostéosarcome | n2=tumeur osseuse | rel=r_associated | relid=0 | w=15
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
Chirurgie
n1=Ostéosarcome | n2=Chirurgie | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:acquired skeletal deformity
n1=Ostéosarcome | n2=en:acquired skeletal deformity | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:acute monoblastic leukemia
n1=Ostéosarcome | n2=en:acute monoblastic leukemia | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:advanced malignant neoplasm
n1=Ostéosarcome | n2=en:advanced malignant neoplasm | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:aggravated malignant neoplasm
n1=Ostéosarcome | n2=en:aggravated malignant neoplasm | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:aids related neoplasm/cancer
n1=Ostéosarcome | n2=en:aids related neoplasm/cancer | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:aids-related malignant neoplasm
n1=Ostéosarcome | n2=en:aids-related malignant neoplasm | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:anal sarcoma
n1=Ostéosarcome | n2=en:anal sarcoma | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:anaplastic malignant neoplasm
n1=Ostéosarcome | n2=en:anaplastic malignant neoplasm | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:angiosarcoma of soft tissue
n1=Ostéosarcome | n2=en:angiosarcoma of soft tissue | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:arthropathy
n1=Ostéosarcome | n2=en:arthropathy | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:bence jones proteins increased
n1=Ostéosarcome | n2=en:bence jones proteins increased | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:bilateral malignant neoplasm
n1=Ostéosarcome | n2=en:bilateral malignant neoplasm | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:bile duct carcinoma
n1=Ostéosarcome | n2=en:bile duct carcinoma | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:biliary tract neoplasm
n1=Ostéosarcome | n2=en:biliary tract neoplasm | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:biopsy
n1=Ostéosarcome | n2=en:biopsy | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:bladder sarcoma
n1=Ostéosarcome | n2=en:bladder sarcoma | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:blood or lymphatic cancer
n1=Ostéosarcome | n2=en:blood or lymphatic cancer | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:body system/site cancer
n1=Ostéosarcome | n2=en:body system/site cancer | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:bone
n1=Ostéosarcome | n2=en:bone | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:bone diseases
n1=Ostéosarcome | n2=en:bone diseases | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:bone disorders, general and nec
n1=Ostéosarcome | n2=en:bone disorders, general and nec | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:bone epithelioid hemangioendothelioma
n1=Ostéosarcome | n2=en:bone epithelioid hemangioendothelioma | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:bone implant lysis of
n1=Ostéosarcome | n2=en:bone implant lysis of | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:bone necrosis
n1=Ostéosarcome | n2=en:bone necrosis | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:bone neoplasms malignant (excl sarcomas)
n1=Ostéosarcome | n2=en:bone neoplasms malignant (excl sarcomas) | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:bone neoplasms unspecified malignancy
n1=Ostéosarcome | n2=en:bone neoplasms unspecified malignancy | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:bone pain adverse event
n1=Ostéosarcome | n2=en:bone pain adverse event | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:calcium metabolism disorders
n1=Ostéosarcome | n2=en:calcium metabolism disorders | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:cancer alternative therapies
n1=Ostéosarcome | n2=en:cancer alternative therapies | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:cancer of nose
n1=Ostéosarcome | n2=en:cancer of nose | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:cancer--living with cancer
n1=Ostéosarcome | n2=en:cancer--living with cancer | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:cancer-related condition
n1=Ostéosarcome | n2=en:cancer-related condition | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:carcinogenesis
n1=Ostéosarcome | n2=en:carcinogenesis | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:carcinosarcoma of skin
n1=Ostéosarcome | n2=en:carcinosarcoma of skin | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:cardiac sarcoma
n1=Ostéosarcome | n2=en:cardiac sarcoma | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:cardiovascular neoplasm
n1=Ostéosarcome | n2=en:cardiovascular neoplasm | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:cartilage development disorder
n1=Ostéosarcome | n2=en:cartilage development disorder | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:cartilage diseases
n1=Ostéosarcome | n2=en:cartilage diseases | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:cartilage sarcomas
n1=Ostéosarcome | n2=en:cartilage sarcomas | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:central nervous system neoplasm
n1=Ostéosarcome | n2=en:central nervous system neoplasm | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:central nervous system sarcoma
n1=Ostéosarcome | n2=en:central nervous system sarcoma | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:cervical angiosarcoma
n1=Ostéosarcome | n2=en:cervical angiosarcoma | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:cervical cancer
n1=Ostéosarcome | n2=en:cervical cancer | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:cervical cancer screening
n1=Ostéosarcome | n2=en:cervical cancer screening | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:cervical leiomyosarcoma
n1=Ostéosarcome | n2=en:cervical leiomyosarcoma | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:cervical malignant peripheral nerve sheath tumor
n1=Ostéosarcome | n2=en:cervical malignant peripheral nerve sheath tumor | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:cervical neoplasm
n1=Ostéosarcome | n2=en:cervical neoplasm | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:cervical rhabdomyosarcoma
n1=Ostéosarcome | n2=en:cervical rhabdomyosarcoma | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:cervicobrachial syndrome
n1=Ostéosarcome | n2=en:cervicobrachial syndrome | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:chemotherapy
n1=Ostéosarcome | n2=en:chemotherapy | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:choriocarcinoma
n1=Ostéosarcome | n2=en:choriocarcinoma | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:chronic leukemia
n1=Ostéosarcome | n2=en:chronic leukemia | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:chronic monocytic leukemia
n1=Ostéosarcome | n2=en:chronic monocytic leukemia | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:chronic myelogenous leukemia, bcr-abl1 positive
n1=Ostéosarcome | n2=en:chronic myelogenous leukemia, bcr-abl1 positive | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:colon polyp
n1=Ostéosarcome | n2=en:colon polyp | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:colorectal sarcoma
n1=Ostéosarcome | n2=en:colorectal sarcoma | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:congenital anomaly of thoracic cage
n1=Ostéosarcome | n2=en:congenital anomaly of thoracic cage | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:congenital skeletal disorder
n1=Ostéosarcome | n2=en:congenital skeletal disorder | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:connective tissue
n1=Ostéosarcome | n2=en:connective tissue | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:cutaneous fibrosarcoma
n1=Ostéosarcome | n2=en:cutaneous fibrosarcoma | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:cutaneous leiomyosarcoma
n1=Ostéosarcome | n2=en:cutaneous leiomyosarcoma | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:diffuse idiopathic skeletal hyperostosis
n1=Ostéosarcome | n2=en:diffuse idiopathic skeletal hyperostosis | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:digestive system neoplasm
n1=Ostéosarcome | n2=en:digestive system neoplasm | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:disorder of skeletal system
n1=Ostéosarcome | n2=en:disorder of skeletal system | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:disorder of tendon
n1=Ostéosarcome | n2=en:disorder of tendon | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:disseminated malignant neoplasm
n1=Ostéosarcome | n2=en:disseminated malignant neoplasm | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:disseminated malignant neoplasm, unspecified
n1=Ostéosarcome | n2=en:disseminated malignant neoplasm, unspecified | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:end stage cancer
n1=Ostéosarcome | n2=en:end stage cancer | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:endocrine system cancer
n1=Ostéosarcome | n2=en:endocrine system cancer | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:endometrial neoplasm
n1=Ostéosarcome | n2=en:endometrial neoplasm | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:environment related neoplasm/cancer
n1=Ostéosarcome | n2=en:environment related neoplasm/cancer | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:environment-related malignant neoplasm
n1=Ostéosarcome | n2=en:environment-related malignant neoplasm | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:epithelioid cell sarcoma of skin
n1=Ostéosarcome | n2=en:epithelioid cell sarcoma of skin | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:esophageal sarcoma
n1=Ostéosarcome | n2=en:esophageal sarcoma | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:ewing sarcoma/peripheral primitive neuroectodermal tumor of bone
n1=Ostéosarcome | n2=en:ewing sarcoma/peripheral primitive neuroectodermal tumor of bone | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:ewing's sarcoma of soft tissue
n1=Ostéosarcome | n2=en:ewing's sarcoma of soft tissue | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:extrahepatic bile duct sarcoma
n1=Ostéosarcome | n2=en:extrahepatic bile duct sarcoma | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:fallopian tube leiomyosarcoma
n1=Ostéosarcome | n2=en:fallopian tube leiomyosarcoma | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:fluoride poisoning
n1=Ostéosarcome | n2=en:fluoride poisoning | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:gallbladder sarcoma
n1=Ostéosarcome | n2=en:gallbladder sarcoma | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:gastric leiomyosarcoma
n1=Ostéosarcome | n2=en:gastric leiomyosarcoma | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:gastric liposarcoma
n1=Ostéosarcome | n2=en:gastric liposarcoma | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:gene mutation-related cancer
n1=Ostéosarcome | n2=en:gene mutation-related cancer | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:genital cancer
n1=Ostéosarcome | n2=en:genital cancer | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:genitourinary neoplasms
n1=Ostéosarcome | n2=en:genitourinary neoplasms | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:head or neck cancer
n1=Ostéosarcome | n2=en:head or neck cancer | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:hepatocellular carcinoma
n1=Ostéosarcome | n2=en:hepatocellular carcinoma | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:hereditary malignant neoplasm
n1=Ostéosarcome | n2=en:hereditary malignant neoplasm | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:hormone related neoplasm/cancer
n1=Ostéosarcome | n2=en:hormone related neoplasm/cancer | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:host-tumor interaction
n1=Ostéosarcome | n2=en:host-tumor interaction | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:immunodeficiency-related malignant neoplasm
n1=Ostéosarcome | n2=en:immunodeficiency-related malignant neoplasm | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:interspinous osteoarthritis
n1=Ostéosarcome | n2=en:interspinous osteoarthritis | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:intimal sarcoma
n1=Ostéosarcome | n2=en:intimal sarcoma | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:intra-abdominal cancer advanced
n1=Ostéosarcome | n2=en:intra-abdominal cancer advanced | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:invasive malignant neoplasm
n1=Ostéosarcome | n2=en:invasive malignant neoplasm | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:laryngeal neoplasm
n1=Ostéosarcome | n2=en:laryngeal neoplasm | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:laryngeal sarcoma
n1=Ostéosarcome | n2=en:laryngeal sarcoma | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:leiomyosarcoma of connective tissue
n1=Ostéosarcome | n2=en:leiomyosarcoma of connective tissue | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:liver neoplasms
n1=Ostéosarcome | n2=en:liver neoplasms | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:local recurrence of malignant tumor of bone
n1=Ostéosarcome | n2=en:local recurrence of malignant tumor of bone | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:localized malignant neoplasm
n1=Ostéosarcome | n2=en:localized malignant neoplasm | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:low grade fibromyxoid sarcoma
n1=Ostéosarcome | n2=en:low grade fibromyxoid sarcoma | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:lung carcinoma
n1=Ostéosarcome | n2=en:lung carcinoma | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:lung sarcoma
n1=Ostéosarcome | n2=en:lung sarcoma | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:major salivary gland sarcoma
n1=Ostéosarcome | n2=en:major salivary gland sarcoma | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:male breast carcinoma
n1=Ostéosarcome | n2=en:male breast carcinoma | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant (primary) neoplasm, unspecified
n1=Ostéosarcome | n2=en:malignant (primary) neoplasm, unspecified | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant adrenal gland neoplasm
n1=Ostéosarcome | n2=en:malignant adrenal gland neoplasm | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant bladder neoplasm
n1=Ostéosarcome | n2=en:malignant bladder neoplasm | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant chest wall bone neoplasm
n1=Ostéosarcome | n2=en:malignant chest wall bone neoplasm | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant connective and soft tissue cell
n1=Ostéosarcome | n2=en:malignant connective and soft tissue cell | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant endocrine neoplasm
n1=Ostéosarcome | n2=en:malignant endocrine neoplasm | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant eye neoplasm
n1=Ostéosarcome | n2=en:malignant eye neoplasm | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant fibromatous neoplasm
n1=Ostéosarcome | n2=en:malignant fibromatous neoplasm | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant gastric neoplasm
n1=Ostéosarcome | n2=en:malignant gastric neoplasm | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant head and neck neoplasm
n1=Ostéosarcome | n2=en:malignant head and neck neoplasm | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant intestinal neoplasm
n1=Ostéosarcome | n2=en:malignant intestinal neoplasm | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant kidney neoplasm
n1=Ostéosarcome | n2=en:malignant kidney neoplasm | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant lipomatous neoplasm
n1=Ostéosarcome | n2=en:malignant lipomatous neoplasm | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant lung neoplasm
n1=Ostéosarcome | n2=en:malignant lung neoplasm | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant neoplasm after immunosuppressive therapy
n1=Ostéosarcome | n2=en:malignant neoplasm after immunosuppressive therapy | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant neoplasm associated with aids
n1=Ostéosarcome | n2=en:malignant neoplasm associated with aids | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant neoplasm associated with transplant organ
n1=Ostéosarcome | n2=en:malignant neoplasm associated with transplant organ | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant neoplasm by grade
n1=Ostéosarcome | n2=en:malignant neoplasm by grade | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant neoplasm growth accelerated
n1=Ostéosarcome | n2=en:malignant neoplasm growth accelerated | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant neoplasm of abdomen
n1=Ostéosarcome | n2=en:malignant neoplasm of abdomen | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant neoplasm of anorectum
n1=Ostéosarcome | n2=en:malignant neoplasm of anorectum | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant neoplasm of bone of lower limb
n1=Ostéosarcome | n2=en:malignant neoplasm of bone of lower limb | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant neoplasm of bones of skull and face
n1=Ostéosarcome | n2=en:malignant neoplasm of bones of skull and face | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant neoplasm of bones of skull and face, except mandible
n1=Ostéosarcome | n2=en:malignant neoplasm of bones of skull and face, except mandible | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant neoplasm of carpal bones
n1=Ostéosarcome | n2=en:malignant neoplasm of carpal bones | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant neoplasm of connective and other soft tissue of abdomen
n1=Ostéosarcome | n2=en:malignant neoplasm of connective and other soft tissue of abdomen | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant neoplasm of connective and other soft tissue of head, face, and neck
n1=Ostéosarcome | n2=en:malignant neoplasm of connective and other soft tissue of head, face, and neck | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant neoplasm of connective and other soft tissue of lower limb, including hip
n1=Ostéosarcome | n2=en:malignant neoplasm of connective and other soft tissue of lower limb, including hip | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant neoplasm of connective and other soft tissue of pelvis
n1=Ostéosarcome | n2=en:malignant neoplasm of connective and other soft tissue of pelvis | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant neoplasm of connective and other soft tissue of thorax
n1=Ostéosarcome | n2=en:malignant neoplasm of connective and other soft tissue of thorax | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant neoplasm of connective and other soft tissue of trunk, unspecified
n1=Ostéosarcome | n2=en:malignant neoplasm of connective and other soft tissue of trunk, unspecified | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant neoplasm of connective and other soft tissue of upper limb, including shoulder
n1=Ostéosarcome | n2=en:malignant neoplasm of connective and other soft tissue of upper limb, including shoulder | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant neoplasm of gartner's duct
n1=Ostéosarcome | n2=en:malignant neoplasm of gartner's duct | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant neoplasm of hand bones
n1=Ostéosarcome | n2=en:malignant neoplasm of hand bones | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant neoplasm of laryngeal cartilage
n1=Ostéosarcome | n2=en:malignant neoplasm of laryngeal cartilage | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant neoplasm of liver
n1=Ostéosarcome | n2=en:malignant neoplasm of liver | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant neoplasm of long bones of lower limb
n1=Ostéosarcome | n2=en:malignant neoplasm of long bones of lower limb | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant neoplasm of lower jaw bone
n1=Ostéosarcome | n2=en:malignant neoplasm of lower jaw bone | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant neoplasm of lower limb
n1=Ostéosarcome | n2=en:malignant neoplasm of lower limb | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant neoplasm of multiple primary sites
n1=Ostéosarcome | n2=en:malignant neoplasm of multiple primary sites | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant neoplasm of other and ill-defined sites: other ill-defined sites
n1=Ostéosarcome | n2=en:malignant neoplasm of other and ill-defined sites: other ill-defined sites | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant neoplasm of other connective and soft tissue
n1=Ostéosarcome | n2=en:malignant neoplasm of other connective and soft tissue | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant neoplasm of other specified sites
n1=Ostéosarcome | n2=en:malignant neoplasm of other specified sites | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant neoplasm of other specified sites of connective and other soft tissue
n1=Ostéosarcome | n2=en:malignant neoplasm of other specified sites of connective and other soft tissue | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant neoplasm of pelvic bones, sacrum and coccyx
n1=Ostéosarcome | n2=en:malignant neoplasm of pelvic bones, sacrum and coccyx | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant neoplasm of pelvis
n1=Ostéosarcome | n2=en:malignant neoplasm of pelvis | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant neoplasm of respiratory system
n1=Ostéosarcome | n2=en:malignant neoplasm of respiratory system | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant neoplasm of ribs, sternum and clavicle
n1=Ostéosarcome | n2=en:malignant neoplasm of ribs, sternum and clavicle | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant neoplasm of scapula and long bones of upper arm
n1=Ostéosarcome | n2=en:malignant neoplasm of scapula and long bones of upper arm | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant neoplasm of scapula and long bones of upper limb
n1=Ostéosarcome | n2=en:malignant neoplasm of scapula and long bones of upper limb | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant neoplasm of short bones of lower limb
n1=Ostéosarcome | n2=en:malignant neoplasm of short bones of lower limb | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant neoplasm of short bones of upper limb
n1=Ostéosarcome | n2=en:malignant neoplasm of short bones of upper limb | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant neoplasm of thoracic vertebral column
n1=Ostéosarcome | n2=en:malignant neoplasm of thoracic vertebral column | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant neoplasm of upper limb bones and scapula
n1=Ostéosarcome | n2=en:malignant neoplasm of upper limb bones and scapula | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant neoplasm of upper limb nos
n1=Ostéosarcome | n2=en:malignant neoplasm of upper limb nos | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant neoplasm of vertebral column
n1=Ostéosarcome | n2=en:malignant neoplasm of vertebral column | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant neoplasm of vertebral column, excluding sacrum and coccyx
n1=Ostéosarcome | n2=en:malignant neoplasm of vertebral column, excluding sacrum and coccyx | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant neoplasm of xiphoid process
n1=Ostéosarcome | n2=en:malignant neoplasm of xiphoid process | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant neoplasm, primary site unknown, so stated
n1=Ostéosarcome | n2=en:malignant neoplasm, primary site unknown, so stated | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant neoplasms of ill-defined, secondary and unspecified sites
n1=Ostéosarcome | n2=en:malignant neoplasms of ill-defined, secondary and unspecified sites | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue
n1=Ostéosarcome | n2=en:malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue
n1=Ostéosarcome | n2=en:malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant neoplastic disease co-occurrent with human immunodeficiency virus infection
n1=Ostéosarcome | n2=en:malignant neoplastic disease co-occurrent with human immunodeficiency virus infection | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant neoplastic disease in mother complicating childbirth
n1=Ostéosarcome | n2=en:malignant neoplastic disease in mother complicating childbirth | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant neoplastic disease in pregnancy
n1=Ostéosarcome | n2=en:malignant neoplastic disease in pregnancy | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant nervous system neoplasm
n1=Ostéosarcome | n2=en:malignant nervous system neoplasm | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant osteoclastic giant cell-rich tumor of bone
n1=Ostéosarcome | n2=en:malignant osteoclastic giant cell-rich tumor of bone | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant sacral teratoma
n1=Ostéosarcome | n2=en:malignant sacral teratoma | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant skin appendage neoplasm
n1=Ostéosarcome | n2=en:malignant skin appendage neoplasm | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant soft tissue neoplasm
n1=Ostéosarcome | n2=en:malignant soft tissue neoplasm | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant solid tumor
n1=Ostéosarcome | n2=en:malignant solid tumor | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant thoracic neoplasm
n1=Ostéosarcome | n2=en:malignant thoracic neoplasm | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant thymus neoplasm
n1=Ostéosarcome | n2=en:malignant thymus neoplasm | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant tumor involving an organ by direct extension from bladder
n1=Ostéosarcome | n2=en:malignant tumor involving an organ by direct extension from bladder | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant tumor involving an organ by direct extension from endometrium
n1=Ostéosarcome | n2=en:malignant tumor involving an organ by direct extension from endometrium | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant tumor involving an organ by direct extension from fallopian tube
n1=Ostéosarcome | n2=en:malignant tumor involving an organ by direct extension from fallopian tube | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant tumor involving an organ by direct extension from ovary
n1=Ostéosarcome | n2=en:malignant tumor involving an organ by direct extension from ovary | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant tumor involving an organ by direct extension from prostate
n1=Ostéosarcome | n2=en:malignant tumor involving an organ by direct extension from prostate | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant tumor involving an organ by direct extension from uterine cervix
n1=Ostéosarcome | n2=en:malignant tumor involving an organ by direct extension from uterine cervix | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant tumor involving an organ by direct extension from uterus
n1=Ostéosarcome | n2=en:malignant tumor involving an organ by direct extension from uterus | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant tumor involving an organ by direct extension from vagina
n1=Ostéosarcome | n2=en:malignant tumor involving an organ by direct extension from vagina | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant tumor involving vasa deferentia by direct extension from prostate
n1=Ostéosarcome | n2=en:malignant tumor involving vasa deferentia by direct extension from prostate | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant tumor of bone and articular cartilage
n1=Ostéosarcome | n2=en:malignant tumor of bone and articular cartilage | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant tumor of nerve sheath origin
n1=Ostéosarcome | n2=en:malignant tumor of nerve sheath origin | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant tumor of unknown origin or ill-defined site
n1=Ostéosarcome | n2=en:malignant tumor of unknown origin or ill-defined site | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant urinary system neoplasm
n1=Ostéosarcome | n2=en:malignant urinary system neoplasm | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant vaginal neoplasm
n1=Ostéosarcome | n2=en:malignant vaginal neoplasm | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant vulvar neoplasm
n1=Ostéosarcome | n2=en:malignant vulvar neoplasm | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:malignant white blood cell disorder
n1=Ostéosarcome | n2=en:malignant white blood cell disorder | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:mediastinal sarcoma
n1=Ostéosarcome | n2=en:mediastinal sarcoma | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:metachronous malignant neoplasm
n1=Ostéosarcome | n2=en:metachronous malignant neoplasm | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:metastatic carcinoma in the bone
n1=Ostéosarcome | n2=en:metastatic carcinoma in the bone | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:metastatic malignant neoplasm of unknown primary origin
n1=Ostéosarcome | n2=en:metastatic malignant neoplasm of unknown primary origin | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:minimal residual disease
n1=Ostéosarcome | n2=en:minimal residual disease | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:moderately differentiated malignant neoplasm
n1=Ostéosarcome | n2=en:moderately differentiated malignant neoplasm | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:multiple malignancy
n1=Ostéosarcome | n2=en:multiple malignancy | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:myxofibrosarcoma of skin
n1=Ostéosarcome | n2=en:myxofibrosarcoma of skin | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:neoplasm of skeletal system
n1=Ostéosarcome | n2=en:neoplasm of skeletal system | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:neoplasm/cancer site
n1=Ostéosarcome | n2=en:neoplasm/cancer site | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:neoplasm/cancer type
n1=Ostéosarcome | n2=en:neoplasm/cancer type | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:neoplasms, connective tissue
n1=Ostéosarcome | n2=en:neoplasms, connective tissue | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:nervous system neoplasm
n1=Ostéosarcome | n2=en:nervous system neoplasm | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:neurofibromatosis
n1=Ostéosarcome | n2=en:neurofibromatosis | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:nodal osteoarthritis
n1=Ostéosarcome | n2=en:nodal osteoarthritis | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:non-hematologic malignancy
n1=Ostéosarcome | n2=en:non-hematologic malignancy | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:nonestrogen-dependent cancer
n1=Ostéosarcome | n2=en:nonestrogen-dependent cancer | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:oral cavity carcinoma
n1=Ostéosarcome | n2=en:oral cavity carcinoma | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:oral cavity neoplasm
n1=Ostéosarcome | n2=en:oral cavity neoplasm | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:oral cavity sarcoma
n1=Ostéosarcome | n2=en:oral cavity sarcoma | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:orbit rhabdomyosarcoma
n1=Ostéosarcome | n2=en:orbit rhabdomyosarcoma | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:orbit sarcoma
n1=Ostéosarcome | n2=en:orbit sarcoma | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:osteoarthritis
n1=Ostéosarcome | n2=en:osteoarthritis | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:osteoarthritis, spine
n1=Ostéosarcome | n2=en:osteoarthritis, spine | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:osteomalacia
n1=Ostéosarcome | n2=en:osteomalacia | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:osteomyelitis
n1=Ostéosarcome | n2=en:osteomyelitis | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:osteophyte, vertebrae
n1=Ostéosarcome | n2=en:osteophyte, vertebrae | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:osteoporosis adverse event
n1=Ostéosarcome | n2=en:osteoporosis adverse event | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:osteoporotic fracture
n1=Ostéosarcome | n2=en:osteoporotic fracture | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:osteosclerosis
n1=Ostéosarcome | n2=en:osteosclerosis | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:pancreatic sarcoma
n1=Ostéosarcome | n2=en:pancreatic sarcoma | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:paranasal sinus sarcoma
n1=Ostéosarcome | n2=en:paranasal sinus sarcoma | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:pathologic fracture
n1=Ostéosarcome | n2=en:pathologic fracture | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:penile sarcoma
n1=Ostéosarcome | n2=en:penile sarcoma | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:periosteal disorder
n1=Ostéosarcome | n2=en:periosteal disorder | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:poorly differentiated malignant neoplasm
n1=Ostéosarcome | n2=en:poorly differentiated malignant neoplasm | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:preneoplastic state
n1=Ostéosarcome | n2=en:preneoplastic state | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:primary lymphoma of bone
n1=Ostéosarcome | n2=en:primary lymphoma of bone | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:primary malignant germ cell neoplasm
n1=Ostéosarcome | n2=en:primary malignant germ cell neoplasm | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:primary malignant neoplasm
n1=Ostéosarcome | n2=en:primary malignant neoplasm | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:primary malignant neoplasm of maxilla (disorder)
n1=Ostéosarcome | n2=en:primary malignant neoplasm of maxilla (disorder) | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:primary sarcoma of tongue
n1=Ostéosarcome | n2=en:primary sarcoma of tongue | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:prostate neoplasm
n1=Ostéosarcome | n2=en:prostate neoplasm | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:prostate sarcoma
n1=Ostéosarcome | n2=en:prostate sarcoma | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:psychological aspect of cancer
n1=Ostéosarcome | n2=en:psychological aspect of cancer | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:radiation therapy
n1=Ostéosarcome | n2=en:radiation therapy | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:radiation-related malignant neoplasm
n1=Ostéosarcome | n2=en:radiation-related malignant neoplasm | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:rapidly progressive osteoarthritis
n1=Ostéosarcome | n2=en:rapidly progressive osteoarthritis | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:recurrent malignant neoplasm
n1=Ostéosarcome | n2=en:recurrent malignant neoplasm | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:refractory malignant neoplasm
n1=Ostéosarcome | n2=en:refractory malignant neoplasm | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:rupture of tendon
n1=Ostéosarcome | n2=en:rupture of tendon | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:sarcoma - category (morphologic abnormality)
n1=Ostéosarcome | n2=en:sarcoma - category (morphologic abnormality) | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:sarcoma of peritoneum
n1=Ostéosarcome | n2=en:sarcoma of peritoneum | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:screening for prostate cancer
n1=Ostéosarcome | n2=en:screening for prostate cancer | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:secondary malignant neoplasm
n1=Ostéosarcome | n2=en:secondary malignant neoplasm | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:secondary neoplasm
n1=Ostéosarcome | n2=en:secondary neoplasm | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:skeletal injury due to birth trauma
n1=Ostéosarcome | n2=en:skeletal injury due to birth trauma | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:skin angiosarcoma
n1=Ostéosarcome | n2=en:skin angiosarcoma | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:skin lymphangiosarcoma
n1=Ostéosarcome | n2=en:skin lymphangiosarcoma | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:small intestinal sarcoma
n1=Ostéosarcome | n2=en:small intestinal sarcoma | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:soft tissue
n1=Ostéosarcome | n2=en:soft tissue | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:soft tissue cancer
n1=Ostéosarcome | n2=en:soft tissue cancer | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:soft tissue fibrosarcoma
n1=Ostéosarcome | n2=en:soft tissue fibrosarcoma | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:solitary osseous plasmacytoma
n1=Ostéosarcome | n2=en:solitary osseous plasmacytoma | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:spina bifida
n1=Ostéosarcome | n2=en:spina bifida | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:spinal diseases
n1=Ostéosarcome | n2=en:spinal diseases | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:stage 0 cervical cancer ajcc v6
n1=Ostéosarcome | n2=en:stage 0 cervical cancer ajcc v6 | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:stage i bone cancer
n1=Ostéosarcome | n2=en:stage i bone cancer | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:stage i soft tissue sarcoma
n1=Ostéosarcome | n2=en:stage i soft tissue sarcoma | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:stage ii bone cancer
n1=Ostéosarcome | n2=en:stage ii bone cancer | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:stage ii soft tissue sarcoma
n1=Ostéosarcome | n2=en:stage ii soft tissue sarcoma | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:stage iii bone cancer
n1=Ostéosarcome | n2=en:stage iii bone cancer | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:stage iii soft tissue sarcoma
n1=Ostéosarcome | n2=en:stage iii soft tissue sarcoma | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:stage iv bone cancer
n1=Ostéosarcome | n2=en:stage iv bone cancer | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:stage iv soft tissue sarcoma
n1=Ostéosarcome | n2=en:stage iv soft tissue sarcoma | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:synovitis
n1=Ostéosarcome | n2=en:synovitis | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:tendon contracture
n1=Ostéosarcome | n2=en:tendon contracture | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:tenosynovitis
n1=Ostéosarcome | n2=en:tenosynovitis | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:testicular sarcoma
n1=Ostéosarcome | n2=en:testicular sarcoma | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:therapy-related malignant neoplasm
n1=Ostéosarcome | n2=en:therapy-related malignant neoplasm | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:throat cancer
n1=Ostéosarcome | n2=en:throat cancer | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:thyroid gland neoplasm
n1=Ostéosarcome | n2=en:thyroid gland neoplasm | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:thyroid gland sarcoma
n1=Ostéosarcome | n2=en:thyroid gland sarcoma | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:tracheal sarcoma
n1=Ostéosarcome | n2=en:tracheal sarcoma | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:transaminase cell carcinoma
n1=Ostéosarcome | n2=en:transaminase cell carcinoma | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:traumatic arthrosis
n1=Ostéosarcome | n2=en:traumatic arthrosis | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:tumor lysis syndrome adverse event
n1=Ostéosarcome | n2=en:tumor lysis syndrome adverse event | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:tumors and pregnancy
n1=Ostéosarcome | n2=en:tumors and pregnancy | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:undifferentiated malignant neoplasm
n1=Ostéosarcome | n2=en:undifferentiated malignant neoplasm | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:undifferentiated/unclassified sarcoma
n1=Ostéosarcome | n2=en:undifferentiated/unclassified sarcoma | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:unresectable malignant neoplasm
n1=Ostéosarcome | n2=en:unresectable malignant neoplasm | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:uterine neoplasm
n1=Ostéosarcome | n2=en:uterine neoplasm | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:vaginal sarcoma
n1=Ostéosarcome | n2=en:vaginal sarcoma | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:virus-related sarcoma
n1=Ostéosarcome | n2=en:virus-related sarcoma | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:well differentiated malignant neoplasm
n1=Ostéosarcome | n2=en:well differentiated malignant neoplasm | rel=r_associated | relid=0 | w=10
- Ostéosarcome --
r_associated #0: 10 / 0.125 ->
en:yolk sac tumor
n1=Ostéosarcome | n2=en:yolk sac tumor | rel=r_associated | relid=0 | w=10
| ≈ 12 relations entrantes
- chirurgie ---
r_associated #0: 70 -->
Ostéosarcome
n1=chirurgie | n2=Ostéosarcome | rel=r_associated | relid=0 | w=70
- carcinologie ---
r_associated #0: 20 -->
Ostéosarcome
n1=carcinologie | n2=Ostéosarcome | rel=r_associated | relid=0 | w=20
- carcinologie
(oncologie) ---
r_associated #0: 20 -->
Ostéosarcome
n1=carcinologie (oncologie) | n2=Ostéosarcome | rel=r_associated | relid=0 | w=20
- en:specialized branches of medicine ---
r_associated #0: 20 -->
Ostéosarcome
n1=en:specialized branches of medicine | n2=Ostéosarcome | rel=r_associated | relid=0 | w=20
- en:surgery ---
r_associated #0: 20 -->
Ostéosarcome
n1=en:surgery | n2=Ostéosarcome | rel=r_associated | relid=0 | w=20
- en:surgical operation ---
r_associated #0: 20 -->
Ostéosarcome
n1=en:surgical operation | n2=Ostéosarcome | rel=r_associated | relid=0 | w=20
- maladies ---
r_associated #0: 20 -->
Ostéosarcome
n1=maladies | n2=Ostéosarcome | rel=r_associated | relid=0 | w=20
- oncologie ---
r_associated #0: 20 -->
Ostéosarcome
n1=oncologie | n2=Ostéosarcome | rel=r_associated | relid=0 | w=20
- pathologie ---
r_associated #0: 20 -->
Ostéosarcome
n1=pathologie | n2=Ostéosarcome | rel=r_associated | relid=0 | w=20
- tumeurs ---
r_associated #0: 20 -->
Ostéosarcome
n1=tumeurs | n2=Ostéosarcome | rel=r_associated | relid=0 | w=20
- Tumeurs ---
r_associated #0: 10 -->
Ostéosarcome
n1=Tumeurs | n2=Ostéosarcome | rel=r_associated | relid=0 | w=10
- cancérologie ---
r_associated #0: 10 -->
Ostéosarcome
n1=cancérologie | n2=Ostéosarcome | rel=r_associated | relid=0 | w=10
|